{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:10:15Z","timestamp":1788765015779,"version":"build-2803163510"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Polyendocrine metabolic ovarian syndrome (PMOS) is a complex endocrine\u2013metabolic disorder affecting up to 18% of women worldwide and remains the leading cause of anovulatory infertility. Despite extensive research, current treatments primarily target symptoms, including menstrual irregularities, hyperandrogenism, and metabolic dysfunction, without addressing the underlying molecular and tissue-level disturbances. Advances in multi\u2011omic profiling have identified disruptions across neuroendocrine, metabolic, inflammatory, and extracellular matrix pathways, alongside genetic susceptibility at loci such as\n                    <jats:italic>DENND1A<\/jats:italic>\n                    ,\n                    <jats:italic>CYP17A1<\/jats:italic>\n                    ,\n                    <jats:italic>LHCGR<\/jats:italic>\n                    ,\n                    <jats:italic>FSHR<\/jats:italic>\n                    ,\n                    <jats:italic>IRS1<\/jats:italic>\n                    , and\n                    <jats:italic>PPARG<\/jats:italic>\n                    . However, the functional roles of many variants remain unresolved. CRISPR\/Cas9 gene editing enables precise interrogation of these pathways, while stem cell\u2013based platforms, including mesenchymal stem cells (MSCs), exosomes, and gene-edited induced pluripotent stem cells (iPSCs), may serve as complementary platforms for regeneration and disease modeling. Preclinical studies demonstrate that MSCs and their derivatives modulate inflammation, restore ovarian structure, and improve metabolic parameters, while iPSC-based models enable patient-specific investigation of steroidogenic and metabolic abnormalities. Translational challenges remain, including targeted delivery, off-target effects, phenotypic heterogeneity, and regulatory considerations. Integrating CRISPR\u2011based functional genomics with stem cell research may shift PMOS management from symptom\u2011focused care to targeted, mechanism\u2011driven interventions that could modify the course of PMOS (Graphical Abstract).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>\n                    Mapping the paradigm shift from symptomatic management to mechanism-driven precision medicine in Polyendocrine Metabolic Ovarian Syndrome (PMOS). The left panel summarizes current clinical challenges defined by purely symptomatic treatments for anovulatory infertility, hyperandrogenism, and metabolic dysfunction, a limitation sustained by a historically poor understanding of underlying disease mechanisms. The middle panel outlines novel biotechnological platforms for mechanistic discovery and therapeutic intervention. Gene function interrogation uses CRISPR\/Cas9 editing to target specific risk loci, including\n                    <jats:italic>DENND1A<\/jats:italic>\n                    ,\n                    <jats:italic>CYP17A1<\/jats:italic>\n                    ,\n                    <jats:italic>IRS1<\/jats:italic>\n                    , and\n                    <jats:italic>PPARG<\/jats:italic>\n                    , to dissect functional pathways governing androgen excess, follicular arrest, and insulin resistance. Stem cell-based strategies employ mesenchymal stem cells (MSCs) and MSC-derived exosomes to modulate systemic inflammation, restore ovarian physiological function, and improve homeostatic metabolic parameters. Patient-specific disease modeling utilizes induced pluripotent stem cells (iPSCs) differentiated into granulosa-like cells or in vitro endometrial models to recapitulate distinct steroidogenic and metabolic abnormalities. The right panel illustrates the ultimate clinical goal of these integrated approaches, demonstrating how transitioning to targeted therapies establishes a balanced endocrine-metabolic profile, improves reproductive function, and reduces long-term metabolic risks, successfully moving the field toward mechanism-driven care and precision medicine. This figure was created with BioRender.com.\n                  <\/jats:p>","DOI":"10.1007\/s12015-026-11188-4","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:39:20Z","timestamp":1783395560000},"page":"3056-3080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From Gene Function to Precision Intervention: CRISPR\/Cas9 and Stem Cell-Based Strategies as Emerging Disease-Modifying Approaches in PMOS"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2976-2319","authenticated-orcid":false,"given":"Masuma","family":"Khatun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Tuuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha S.","family":"Tapanainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Salumets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"11188_CR1","doi-asserted-by":"publisher","unstructured":"Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., \u2026 Teede, H. J. (2022). Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology, 10(9), 668\u2013680. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2","DOI":"10.1016\/S2213-8587(22)00163-2"},{"key":"11188_CR2","doi-asserted-by":"publisher","unstructured":"Palomba, S., Costanzi, F., Seminara, G., Caserta, D., & Aversa, A. (2026). Is polycystic ovary syndrome associated with uterine malformations? A systematic review using Bradford Hill\u2019s causality framework. Human reproduction open, 2026(1), hoag005. https:\/\/doi.org\/10.1093\/hropen\/hoag005","DOI":"10.1093\/hropen\/hoag005"},{"key":"11188_CR3","doi-asserted-by":"publisher","unstructured":"Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., \u2026 Piltonen, T. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(26)00717-8","DOI":"10.1016\/S0140-6736(26)00717-8"},{"key":"11188_CR4","doi-asserted-by":"publisher","unstructured":"Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., \u2026 Piltonen, T. T. (2024). Polycystic ovary syndrome. Nat Rev Dis Primers, 10(1), 27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3","DOI":"10.1038\/s41572-024-00511-3"},{"key":"11188_CR5","doi-asserted-by":"publisher","unstructured":"Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2025). POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: an evolutionary metabolic adaptation. Reproduction (Cambridge, England), 169(4). https:\/\/doi.org\/10.1530\/REP-25-0021","DOI":"10.1530\/REP-25-0021"},{"issue":"1","key":"11188_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12905-024-03537-7","volume":"25","author":"M Huo","year":"2025","unstructured":"Huo, M., Wang, Y., Yuan, X., Yuan, Y., & Zhang, X. (2025). Changing trends in the global burden of polycystic ovarian syndrome-related infertility over the past 30 years: Retrospective data analysis of the global burden of disease study 2019. BMC Women\u2019s Health, 25(1), 35. https:\/\/doi.org\/10.1186\/s12905-024-03537-7","journal-title":"BMC Women\u2019s Health"},{"key":"11188_CR7","doi-asserted-by":"publisher","unstructured":"Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., \u2026 Tan, K. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal of Endocrinology, 189(2). https:\/\/doi.org\/10.1093\/ejendo\/lvad096","DOI":"10.1093\/ejendo\/lvad096"},{"key":"11188_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119874042","author":"TM Barber","year":"2019","unstructured":"Barber, T. M., Hanson, P., Weickert, M. O., & Franks, S. (2019). Obesity and polycystic ovary syndrome: Implications for pathogenesis and novel management strategies. Clinical Medicine Insights: Reproductive Health. https:\/\/doi.org\/10.1177\/1179558119874042","journal-title":"Clinical Medicine Insights: Reproductive Health"},{"key":"11188_CR9","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i3.129","author":"CA Amisi","year":"2022","unstructured":"Amisi, C. A. (2022). Markers of insulin resistance in polycystic ovary syndrome women: An update. World Journal of Diabetes. https:\/\/doi.org\/10.4239\/wjd.v13.i3.129","journal-title":"World Journal of Diabetes"},{"key":"11188_CR10","doi-asserted-by":"publisher","unstructured":"Torstensson, S., Ascani, A., Risal, S., Lu, H., Zhao, A., Espinosa, A., \u2026 Stener-Victorin, E. (2024). Androgens Modulate the Immune Profile in a Mouse Model of Polycystic Ovary Syndrome. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11(28), e2401772. https:\/\/doi.org\/10.1002\/advs.202401772","DOI":"10.1002\/advs.202401772"},{"issue":"16","key":"11188_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033572","volume":"13","author":"CT Tay","year":"2024","unstructured":"Tay, C. T., Mousa, A., Vyas, A., Pattuwage, L., Tehrani, F. R., & Teede, H. (2024). 2023 International evidence-based polycystic ovary syndrome guideline update: Insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome. Journal of the American Heart Association, 13(16), Article e033572. https:\/\/doi.org\/10.1161\/JAHA.123.033572","journal-title":"Journal of the American Heart Association"},{"key":"11188_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125","author":"F Guo","year":"2022","unstructured":"Guo, F., Gong, Z., Fernando, T., Zhang, L., Zhu, X., & Shi, Y. (2022). The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: A retrospective study in Chinese population. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2022.892125","journal-title":"Frontiers in Endocrinology"},{"key":"11188_CR13","doi-asserted-by":"publisher","unstructured":"Alur-Gupta, S., Chemerinski, A., Liu, C., Lipson, J., Allison, K., Sammel, M. D., & Dokras, A. (2019). Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertility and Sterility, 112(5). https:\/\/doi.org\/10.1016\/j.fertnstert.2019.06.018","DOI":"10.1016\/j.fertnstert.2019.06.018"},{"key":"11188_CR14","doi-asserted-by":"publisher","unstructured":"Paschou, S. A., Polyzos, S. A., Anagnostis, P., Goulis, D. G., Kanaka-Gantenbein, C., Lambrinoudaki, I., \u2026 Vryonidou, A. (2019). Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Endocrine, 67(1), 1\u20138. https:\/\/doi.org\/10.1007\/s12020-019-02085-7","DOI":"10.1007\/s12020-019-02085-7"},{"key":"11188_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13754","author":"JE Johnson","year":"2023","unstructured":"Johnson, J. E., Daley, D., Tarta, C., & Stanciu, P. I. (2023). Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta-analysis. Oncology Letters. https:\/\/doi.org\/10.3892\/ol.2023.13754","journal-title":"Oncology Letters"},{"key":"11188_CR16","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i3.240","author":"W-T Liao","year":"2022","unstructured":"Liao, W.-T., Huang, J.-Y., Lee, M.-T., Yang, Y.-C., & Wu, C.-C. (2022). Higher risk of type 2 diabetes in young women with polycystic ovary syndrome: A 10-year retrospective cohort study. World Journal of Diabetes. https:\/\/doi.org\/10.4239\/wjd.v13.i3.240","journal-title":"World Journal of Diabetes"},{"key":"11188_CR17","doi-asserted-by":"publisher","unstructured":"Pe\u00f1a, A. S., Witchel, S. F., Boivin, J., Burgert, T. S., Ee, C., Hoeger, K. M., \u2026 Teede, H. (2025). International evidence-based recommendations for polycystic ovary syndrome in adolescents. BMC Medicine, 23(1), 151. https:\/\/doi.org\/10.1186\/s12916-025-03901-w","DOI":"10.1186\/s12916-025-03901-w"},{"key":"11188_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124021","author":"J Parker","year":"2025","unstructured":"Parker, J., Briden, L., & Gersh, F. L. (2025). Recognizing the role of insulin resistance in polycystic ovary syndrome: A paradigm shift from a glucose-centric approach to an insulin-centric model. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm14124021","journal-title":"Journal of Clinical Medicine"},{"key":"11188_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000548","author":"J Dong","year":"2023","unstructured":"Dong, J., & Rees, D. A. (2023). Polycystic ovary syndrome: Pathophysiology and therapeutic opportunities. BMJ Medicine. https:\/\/doi.org\/10.1136\/bmjmed-2023-000548","journal-title":"BMJ Medicine"},{"key":"11188_CR20","doi-asserted-by":"publisher","unstructured":"Gao, X., Zhao, S., Du, Y., Yang, Z., Tian, Y., Zhao, J., \u2026 Network, C. W. R. M. (2025). Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes. Nature Medicine, 31(12), 4214\u20134224. https:\/\/doi.org\/10.1038\/s41591-025-03984-1","DOI":"10.1038\/s41591-025-03984-1"},{"key":"11188_CR21","doi-asserted-by":"publisher","unstructured":"Khatun, M., Lundin, K., Naillat, F., Loog, L., Saarela, U., Tuuri, T., \u2026 Tapanainen, J. S. (2023). Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS). Stem Cell Reviews and Reports. https:\/\/doi.org\/10.1007\/s12015-023-10627-w","DOI":"10.1007\/s12015-023-10627-w"},{"key":"11188_CR22","doi-asserted-by":"publisher","unstructured":"Bucheeri, S., Alcibahy, Y., Bucheeri, Y., Bucheeri, S., Alhermi, A., & Butler, A. E. (2025). CRISPR as a Tool to Uncover Gene Function in Polycystic Ovary Syndrome: A Literature Review of Experimental Models Targeting Ovarian and Metabolic Genes. Cells, 14(22). https:\/\/doi.org\/10.3390\/cells14221769","DOI":"10.3390\/cells14221769"},{"issue":"1","key":"11188_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","volume":"18","author":"P Su","year":"2025","unstructured":"Su, P., Chen, C., & Sun, Y. (2025). Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. Journal of Ovarian Research, 18(1), 34. https:\/\/doi.org\/10.1186\/s13048-025-01621-6","journal-title":"Journal of Ovarian Research"},{"key":"11188_CR24","doi-asserted-by":"publisher","DOI":"10.2196\/48854","author":"TT Piltonen","year":"2024","unstructured":"Piltonen, T. T., Allegranza, D., Hund, M., Buck, K., Sillman, J., & Arffman, R. K. (2024). Validation of an anti-M\u00fcllerian hormone cutoff for polycystic ovarian morphology in the diagnosis of polycystic ovary syndrome in the HARMONIA study: Protocol for a prospective, noninterventional study. JMIR Research Protocols. https:\/\/doi.org\/10.2196\/48854","journal-title":"JMIR Research Protocols"},{"key":"11188_CR25","doi-asserted-by":"publisher","unstructured":"Houston, E. J., & Templeman, N. M. (2025). Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. The Journal of endocrinology, 265(2). https:\/\/doi.org\/10.1530\/JOE-24-0269","DOI":"10.1530\/JOE-24-0269"},{"key":"11188_CR26","doi-asserted-by":"publisher","unstructured":"Jin, C., Wang, X., Yang, J., Kim, S., Hudgins, A. D., Gamliel, A., \u2026 Suh, Y. (2025). Molecular and genetic insights into human ovarian aging from single-nuclei multi-omics analyses. Nature Aging, 5(2), 275\u2013290. https:\/\/doi.org\/10.1038\/s43587-024-00762-5","DOI":"10.1038\/s43587-024-00762-5"},{"key":"11188_CR27","doi-asserted-by":"publisher","unstructured":"Chen, Q., Li, X., Zhou, W., Xiao, J., Yang, Y., Chen, H., \u2026 Chen, X. (2025). Multi-omics analysis reveals synergistic interplay of metabolic dysregulation, oxidative stress, and inflammation in polycystic ovary syndrome. Biomedical Analysis, 2(2), 51\u201361. https:\/\/doi.org\/10.1016\/j.bioana.2025.06.002","DOI":"10.1016\/j.bioana.2025.06.002"},{"key":"11188_CR28","doi-asserted-by":"publisher","unstructured":"Piltonen, T. T., Chen, J. C., Khatun, M., Kangasniemi, M., Liakka, A., Spitzer, T., \u2026 Giudice, L. C. (2015). Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro. Human Reproduction, 30(5). https:\/\/doi.org\/10.1093\/humrep\/dev055","DOI":"10.1093\/humrep\/dev055"},{"key":"11188_CR29","doi-asserted-by":"publisher","unstructured":"Khatun, M., Arffman, R. K., Lavogina, D., Kangasniemi, M., Laru, J., Ahtikoski, A., \u2026 Piltonen, T. T. (2020). Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1. Biology of Reproduction, 102(2). https:\/\/doi.org\/10.1093\/biolre\/ioz180","DOI":"10.1093\/biolre\/ioz180"},{"key":"11188_CR30","doi-asserted-by":"publisher","unstructured":"Khatun, M., Meltsov, A., Lavogina, D., Loid, M., Kask, K., Arffman, R. K., \u2026 Piltonen, T. T. (2021). Decidualized endometrial stromal cells present with altered androgen response in PCOS. Scientific Reports, 11(1). https:\/\/doi.org\/10.1038\/s41598-021-95705-0","DOI":"10.1038\/s41598-021-95705-0"},{"key":"11188_CR31","doi-asserted-by":"publisher","unstructured":"Eriksson, G., Li, C., Sparovec, T. G., Dekanski, A., Torstensson, S., Risal, S., \u2026 Stener-Victorin, E. (2025). Single-cell profiling of the human endometrium in polycystic ovary syndrome. Nature Medicine, 31(6), 1925\u20131938. https:\/\/doi.org\/10.1038\/s41591-025-03592-z","DOI":"10.1038\/s41591-025-03592-z"},{"issue":"1","key":"11188_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","volume":"23","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar, H., & Arumugam, M. (2025). Gut microbiota: A hidden player in polycystic ovary syndrome. Journal of Translational Medicine, 23(1), 443. https:\/\/doi.org\/10.1186\/s12967-025-06315-7","journal-title":"Journal of Translational Medicine"},{"key":"11188_CR33","doi-asserted-by":"publisher","first-page":"1734041","DOI":"10.3389\/fendo.2026.1734041","volume":"17","author":"B Su","year":"2026","unstructured":"Su, B., Cao, Y., Ma, L., & Huang, J. (2026). BMI-stratified phenotypes of polycystic ovary syndrome: Advances in gut microbiota research and personalized management strategies. Frontiers in endocrinology, 17, 1734041. https:\/\/doi.org\/10.3389\/fendo.2026.1734041","journal-title":"Frontiers in endocrinology"},{"key":"11188_CR34","doi-asserted-by":"publisher","unstructured":"Liu, Y., Zhu, J., Yang, Y., Chen, Z., Zhou, Y., Fei, W., \u2026 Zheng, Y. (2025). Extracellular matrix dysregulation in PCOS: pathogenesis, therapeutic strategies, and innovative technologies. Journal of Biological Engineering, 19(1), 61. https:\/\/doi.org\/10.1186\/s13036-025-00533-9","DOI":"10.1186\/s13036-025-00533-9"},{"key":"11188_CR35","doi-asserted-by":"publisher","unstructured":"Yang, G., Yao, G., Xu, Z., Fan, H., Liu, X., He, J., \u2026 Sun, Y. (2021). Expression Level of ADAMTS1 in Granulosa Cells of PCOS Patients Is Related to Granulosa Cell Function, Oocyte Quality, and Embryo Development. Frontiers in Cell and Developmental Biology, 9. https:\/\/doi.org\/10.3389\/fcell.2021.647522","DOI":"10.3389\/fcell.2021.647522"},{"key":"11188_CR36","doi-asserted-by":"publisher","unstructured":"Hassani, F., Oryan, S., Eftekhari-Yazdi, P., Bazrgar, M., Moini, A., Nasiri, N., & Sharifi-Zarchi, A. (2019). Downregulation of extracellular matrix and cell adhesion molecules in cumulus cells of infertile polycystic ovary syndrome women with and without insulin resistance. Cell Journal, 21(1). https:\/\/doi.org\/10.22074\/cellj.2019.5576","DOI":"10.22074\/cellj.2019.5576"},{"key":"11188_CR37","doi-asserted-by":"publisher","unstructured":"Tharayil, S. P., & Shukla, P. (2025). Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance\u2014Insights and Therapeutic Advances. International Journal of Molecular Sciences, 26(13). https:\/\/doi.org\/10.3390\/ijms26136233","DOI":"10.3390\/ijms26136233"},{"key":"11188_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-025-11104-4","author":"S Zhang","year":"2025","unstructured":"Zhang, S., Zhu, M., & Chen, S. (2025). Exploring the interconnections between mitochondrial dysfunction and polycystic ovary syndrome: A comprehensive integrated analysis. Biochemical Genetics. https:\/\/doi.org\/10.1007\/s10528-025-11104-4","journal-title":"Biochemical Genetics"},{"key":"11188_CR39","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac001","author":"M Dapas","year":"2022","unstructured":"Dapas, M., & Dunaif, A. (2022). Deconstructing a syndrome: Genomic insights into PCOS causal mechanisms and classification. Endocrine Reviews. https:\/\/doi.org\/10.1210\/endrev\/bnac001","journal-title":"Endocrine Reviews"},{"key":"11188_CR40","doi-asserted-by":"publisher","unstructured":"Louwers, Y. V, Visser, J. A., Dunaif, A., & Laven, J. S. E. (2025). POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Genetics of polycystic ovary syndrome (PCOS). Reproduction (Cambridge, England), 170(5). https:\/\/doi.org\/10.1530\/REP-25-0126","DOI":"10.1530\/REP-25-0126"},{"key":"11188_CR41","doi-asserted-by":"publisher","unstructured":"Chaker, W. M.-M., Adi, R. M., Madkour, M., Farhat, N., Abdelrahim, D. N., Saber-Ayad, M., \u2026 Faris, M. E. (2025). Characterizing Genetic, Epigenetic, Nutritional, and Clinico-Biochemical Profile of Women With Polycystic Ovary Syndrome: A Case\u2013Control Study. Journal of Nutrition and Metabolism, 2025(1), 8817919. https:\/\/doi.org\/10.1155\/jnme\/8817919","DOI":"10.1155\/jnme\/8817919"},{"key":"11188_CR42","doi-asserted-by":"publisher","unstructured":"Tyrmi, J. S., Arffman, R. K., Pujol-Gualdo, N., Kurra, V., Morin-Papunen, L., Sliz, E., \u2026 Laivuori, H. (2022). Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Human Reproduction, 37(2), 352\u2013365. https:\/\/doi.org\/10.1093\/humrep\/deab250","DOI":"10.1093\/humrep\/deab250"},{"key":"11188_CR43","doi-asserted-by":"publisher","unstructured":"Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., \u2026 Dunaif, A. (2020). Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. PLoS Medicine, 17(6). https:\/\/doi.org\/10.1371\/journal.pmed.1003132","DOI":"10.1371\/journal.pmed.1003132"},{"key":"11188_CR44","doi-asserted-by":"publisher","unstructured":"Joo, Y. Y., Actkins, K., Pacheco, J. A., Basile, A. O., Carroll, R., Crosslin, D. R., \u2026 Geoffrey Hayes, M. (2020). A polygenic and phenotypic risk prediction for polycystic ovary syndrome evaluated by phenomewide association studies. Journal of Clinical Endocrinology and Metabolism, 105(6). https:\/\/doi.org\/10.1210\/clinem\/dgz326","DOI":"10.1210\/clinem\/dgz326"},{"key":"11188_CR45","doi-asserted-by":"publisher","first-page":"1458711","DOI":"10.3389\/fendo.2025.1458711","volume":"16","author":"EE DiPietro","year":"2025","unstructured":"DiPietro, E. E., Sarasua, S. M., Hopkins, C. S., Ganakammal, S. R., Boccuto, L., & Hurwitz, J. (2025). Genetics of ovulatory dysfunction and infertility: A scoping review and gene ontology analysis. Frontiers in endocrinology, 16, 1458711. https:\/\/doi.org\/10.3389\/fendo.2025.1458711","journal-title":"Frontiers in endocrinology"},{"key":"11188_CR46","doi-asserted-by":"publisher","unstructured":"Zhao, H., Xu, Y., Xue, B., Zhao, S., Zhang, M., Wu, X. K., \u2026 Shi, Y. (2025). Multi-ancestry genome-wide association analyses of polycystic ovary syndrome. Nature Genetics, 57(11). https:\/\/doi.org\/10.1038\/s41588-025-02393-x","DOI":"10.1038\/s41588-025-02393-x"},{"key":"11188_CR47","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab757","author":"T Zhu","year":"2022","unstructured":"Zhu, T., & Goodarzi, M. O. (2022). Causes and Consequences of Polycystic Ovary Syndrome: Insights from Mendelian Randomization. Journal of Clinical Endocrinology and Metabolism. https:\/\/doi.org\/10.1210\/clinem\/dgab757","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"11188_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead053","author":"LJ Dobbie","year":"2023","unstructured":"Dobbie, L. J., Pittam, B., Zhao, S. S., Alam, U., Hydes, T. J., Barber, T. M., & Cuthbertson, D. J. (2023). Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: A Mendelian randomization study with meta-analysis. Human Reproduction. https:\/\/doi.org\/10.1093\/humrep\/dead053","journal-title":"Human Reproduction"},{"key":"11188_CR49","doi-asserted-by":"publisher","unstructured":"Bauer, R., Parker, C., Cardona Matos, Z., Hayes, M. G., Kunselman, A. R., Legro, R. S., \u2026 Urbanek, M. (2025). Pathogenic variation in insulin resistance genes is common in polycystic ovary syndrome (PCOS): a strategy for causal gene discovery using whole-exome sequencing (WES) in complex traits. medRxiv, 2025.08.13.25333592. https:\/\/doi.org\/10.1101\/2025.08.13.25333592","DOI":"10.1101\/2025.08.13.25333592"},{"key":"11188_CR50","doi-asserted-by":"publisher","unstructured":"Crespo, R. P., Rocha, T. P., Montenegro, L. R., Nishi, M. Y., Jorge, A. A. L., Maciel, G. A. R., \u2026 Gomes, L. G. (2022). High-throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort. Journal of the Endocrine Society, 6(9), bvac106. https:\/\/doi.org\/10.1210\/jendso\/bvac106","DOI":"10.1210\/jendso\/bvac106"},{"key":"11188_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020302","author":"R Heidarzadehpilehrood","year":"2022","unstructured":"Heidarzadehpilehrood, R., Pirhoushiaran, M., Abdollahzadeh, R., Osman, M. B., Sakinah, M., Nordin, N., & Hamid, H. A. (2022). A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: Candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility. Genes. https:\/\/doi.org\/10.3390\/genes13020302","journal-title":"Genes"},{"key":"11188_CR52","doi-asserted-by":"publisher","unstructured":"Sankaranarayanan, L., Brewer, K. J., Morrow, S., Johnson, G. D., Barrera, A., Venukuttan, R., \u2026 Reddy, T. E. (2025). Gene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production. Nature Communications, 16(1), 7697. https:\/\/doi.org\/10.1038\/s41467-025-62884-7","DOI":"10.1038\/s41467-025-62884-7"},{"issue":"5","key":"11188_CR53","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tem.2024.12.002","volume":"36","author":"E Stener-Victorin","year":"2025","unstructured":"Stener-Victorin, E., & Deng, Q. (2025). Epigenetic inheritance of PCOS by developmental programming and germline transmission. Trends in Endocrinology & Metabolism, 36(5), 472\u2013481. https:\/\/doi.org\/10.1016\/j.tem.2024.12.002","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"6","key":"11188_CR54","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/humrep\/deae066","volume":"39","author":"C Vatier","year":"2024","unstructured":"Vatier, C., & Christin-Maitre, S. (2024). Epigenetic\/circadian clocks and PCOS. Human Reproduction, 39(6), 1167\u20131175. https:\/\/doi.org\/10.1093\/humrep\/deae066","journal-title":"Human Reproduction"},{"key":"11188_CR55","doi-asserted-by":"publisher","unstructured":"Mani, S., Srivastava, V., Shandilya, C., Kaushik, A., & Singh, K. K. (2024). Mitochondria: the epigenetic regulators of ovarian aging and longevity. Frontiers in Endocrinology, 15\u20132024. https:\/\/doi.org\/10.3389\/fendo.2024.1424826","DOI":"10.3389\/fendo.2024.1424826"},{"key":"11188_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09789-2","author":"P Shukla","year":"2023","unstructured":"Shukla, P., & Melkani, G. C. (2023). Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS. Reviews in Endocrine and Metabolic Disorders. https:\/\/doi.org\/10.1007\/s11154-023-09789-2","journal-title":"Reviews in Endocrine and Metabolic Disorders"},{"key":"11188_CR57","doi-asserted-by":"publisher","unstructured":"Goodarzi, M. O., Jones, M. R., Li, X., Chua, A. K., Garcia, O. A., Chen, Y. D. I., \u2026 Urbanek, M. (2012). Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. Journal of Medical Genetics, 49(2). https:\/\/doi.org\/10.1136\/jmedgenet-2011-100427","DOI":"10.1136\/jmedgenet-2011-100427"},{"issue":"2","key":"11188_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/13102818.2017.1423246","volume":"32","author":"R Robeva","year":"2018","unstructured":"Robeva, R., Andonova, S., Tomova, A., Kumanov, P., & Savov, A. (2018). LHCG receptor polymorphisms in PCOS patients. Biotechnology & Biotechnological Equipment, 32(2), 427\u2013432. https:\/\/doi.org\/10.1080\/13102818.2017.1423246","journal-title":"Biotechnology & Biotechnological Equipment"},{"key":"11188_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2025.102307","volume":"41","author":"DJ Patel","year":"2025","unstructured":"Patel, D. J., Mistry, K. N., Gujarathi, J., & Chudasama, P. (2025). Genetic and hormonal insights into PCOS: Role of FSHR rs6166 and LHCGR rs2293275 polymorphisms. Gene Reports, 41, Article 102307. https:\/\/doi.org\/10.1016\/j.genrep.2025.102307","journal-title":"Gene Reports"},{"key":"11188_CR60","doi-asserted-by":"publisher","unstructured":"Bohaczuk, S. C., Thackray, V. G., Shen, J., Skowronska-Krawczyk, D., & Mellon, P. L. (2021). FSHB Transcription is Regulated by a Novel 5\u2032 Distal Enhancer with a Fertility-Associated Single Nucleotide Polymorphism. Endocrinology (United States), 162(1). https:\/\/doi.org\/10.1210\/endocr\/bqaa181","DOI":"10.1210\/endocr\/bqaa181"},{"key":"11188_CR61","doi-asserted-by":"publisher","unstructured":"Tian, Y., Zhao, H., Chen, H., Peng, Y., Cui, L., Du, Y., \u2026 Chen, Z. J. (2016). Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in Han Chinese Women. Journal of Clinical Endocrinology and Metabolism, 101(5). https:\/\/doi.org\/10.1210\/jc.2015-3776","DOI":"10.1210\/jc.2015-3776"},{"key":"11188_CR62","doi-asserted-by":"publisher","DOI":"10.22074\/IJFS.2021.524795.1090","author":"L Naserpoor","year":"2022","unstructured":"Naserpoor, L., Jannatifar, R., Roshanaei, K., Khoshandam, M., & Kallhor, N. (2022). Association of rs13429458 and rs12478601 single nucleotide polymorphisms of THADA gene with polycystic ovary syndrome. International Journal of Fertility and Sterility. https:\/\/doi.org\/10.22074\/IJFS.2021.524795.1090","journal-title":"International Journal of Fertility and Sterility"},{"key":"11188_CR63","doi-asserted-by":"publisher","unstructured":"Li, M., Zhao, H., Zhao, S. G., Wei, D. M., Zhao, Y. R., Huang, T., \u2026 Chen, Z. J. (2019). The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 104(4). https:\/\/doi.org\/10.1210\/jc.2018-00544","DOI":"10.1210\/jc.2018-00544"},{"issue":"1","key":"11188_CR64","doi-asserted-by":"publisher","first-page":"16596","DOI":"10.1038\/s41598-024-67461-4","volume":"14","author":"X Li","year":"2024","unstructured":"Li, X., Gao, B., Gao, B., Li, X., & Xia, X. (2024). Transcriptome profiling reveals dysregulation of inflammatory and protein synthesis genes in PCOS. Scientific Reports, 14(1), 16596. https:\/\/doi.org\/10.1038\/s41598-024-67461-4","journal-title":"Scientific Reports"},{"key":"11188_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01091-0","author":"H Zhao","year":"2023","unstructured":"Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"Journal of Ovarian Research"},{"key":"11188_CR66","doi-asserted-by":"publisher","unstructured":"Daghestani, M. H. (2020). Rs1799817 in INSR associates with susceptibility to polycystic ovary syndrome. Journal of Medical Biochemistry, 39(2). https:\/\/doi.org\/10.2478\/jomb-2019-0023","DOI":"10.2478\/jomb-2019-0023"},{"key":"11188_CR67","doi-asserted-by":"publisher","unstructured":"Xu, T., Xiang, Y., Huang, Z., Zhu, Q., Wu, H., Cai, J., \u2026 Ge, H. (2025). Hyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction. Journal of Ovarian Research, 18(1), 170. https:\/\/doi.org\/10.1186\/s13048-025-01757-5","DOI":"10.1186\/s13048-025-01757-5"},{"key":"11188_CR68","doi-asserted-by":"publisher","unstructured":"Lidaka, L., Bekere, L., Lazdane, G., Lazovska, M., Dzivite-Krisane, I., & Gailite, L. (2022). Role of Single Nucleotide Variants in the YAP1 Gene in Adolescents with Polycystic Ovary Syndrome. Biomedicines, 10(7). https:\/\/doi.org\/10.3390\/biomedicines10071688","DOI":"10.3390\/biomedicines10071688"},{"key":"11188_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7624932","author":"R Dadachanji","year":"2018","unstructured":"Dadachanji, R., Shaikh, N., & Mukherjee, S. (2018). Genetic variants associated with hyperandrogenemia in PCOS pathophysiology. Genetics Research International. https:\/\/doi.org\/10.1155\/2018\/7624932","journal-title":"Genetics Research International"},{"key":"11188_CR70","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., \u2026 Arlt, W. (2017). AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 102(9). https:\/\/doi.org\/10.1210\/jc.2017-00947","DOI":"10.1210\/jc.2017-00947"},{"key":"11188_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2018.07.002","author":"TM Penning","year":"2019","unstructured":"Penning, T. M. (2019). AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): Roles in malignancy and endocrine disorders. Molecular and Cellular Endocrinology. https:\/\/doi.org\/10.1016\/j.mce.2018.07.002","journal-title":"Molecular and Cellular Endocrinology"},{"key":"11188_CR72","doi-asserted-by":"publisher","unstructured":"Wojciechowski, P., Lipowska, A., Rys, P., Ewens, K. G., Franks, S., Tan, S., \u2026 Malecki, M. T. (2012). Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysis. Diabetologia, 55(10). https:\/\/doi.org\/10.1007\/s00125-012-2638-6","DOI":"10.1007\/s00125-012-2638-6"},{"issue":"1","key":"11188_CR73","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-025-01456-2","volume":"23","author":"C Wang","year":"2025","unstructured":"Wang, C., Yang, K., Gao, F., Zheng, M., & Fu, X. (2025). FTO regulates testosterone secretion in Leydig cells: Insights into the role of m6A modifications and the therapeutic potential of hCG. Reproductive Biology and Endocrinology, 23(1), 121. https:\/\/doi.org\/10.1186\/s12958-025-01456-2","journal-title":"Reproductive Biology and Endocrinology"},{"key":"11188_CR74","doi-asserted-by":"publisher","unstructured":"Veikkolainen, V., Ali, N., Doroszko, M., Kiviniemi, A., Miinalainen, I., Ohlsson, C., \u2026 Naillat, F. (2020). Erbb4 regulates the oocyte microenvironment during folliculogenesis. Human Molecular Genetics, 29(17). https:\/\/doi.org\/10.1093\/hmg\/ddaa161","DOI":"10.1093\/hmg\/ddaa161"},{"key":"11188_CR75","doi-asserted-by":"publisher","unstructured":"Peng, Y., Zhang, W., Yang, P., Tian, Y., Su, S., Zhang, C., \u2026 Zhao, H. (2017). ERBB4 Confers Risk for Polycystic Ovary Syndrome in Han Chinese. Scientific Reports, 7. https:\/\/doi.org\/10.1038\/srep42000","DOI":"10.1038\/srep42000"},{"key":"11188_CR76","doi-asserted-by":"publisher","unstructured":"Yang, D., Li, N., Ma, A., Dai, F., Zheng, Y., Hu, X., \u2026 Cheng, Y. (2021). Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis. Reproductive Sciences, 28(5). https:\/\/doi.org\/10.1007\/s43032-020-00352-x","DOI":"10.1007\/s43032-020-00352-x"},{"key":"11188_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00706-3","author":"P Devarbhavi","year":"2021","unstructured":"Devarbhavi, P., Telang, L., Vastrad, B., Tengli, A., Vastrad, C., & Kotturshetti, I. (2021). Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules. Reproductive Biology and Endocrinology. https:\/\/doi.org\/10.1186\/s12958-021-00706-3","journal-title":"Reproductive Biology and Endocrinology"},{"key":"11188_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-026-02038-5","author":"Y Zhang","year":"2026","unstructured":"Zhang, Y., Lin, Y., Xiong, X., Chen, X., Liu, X., & Huang, H. (2026). Integrative bioinformatics, single-cell and experimental evidence for a BPA-m6A-apoptosis axis in granulosa cell dysfunction in polycystic ovary syndrome. Journal of ovarian research. https:\/\/doi.org\/10.1186\/s13048-026-02038-5","journal-title":"Journal of ovarian research"},{"key":"11188_CR79","doi-asserted-by":"publisher","unstructured":"Lu, Z., Chen, C., Gao, Y., Li, Y., Zhao, X., Zhang, H., \u2026 Wan, M. (2022). Screening target genes for the treatment of PCOS via analysis of single-cell sequencing data. Annals of Medicine, 54(1). https:\/\/doi.org\/10.1080\/07853890.2022.2136401","DOI":"10.1080\/07853890.2022.2136401"},{"key":"11188_CR80","doi-asserted-by":"publisher","unstructured":"Zhang, J., Zhang, F. J., Zhang, L., Xian, D. X., Wang, S. A., Peng, M., & Liu, Y. (2023). Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses. European Review for Medical and Pharmacological Sciences, 27(8). https:\/\/doi.org\/10.26355\/eurrev_202304_32097","DOI":"10.26355\/eurrev_202304_32097"},{"issue":"1","key":"11188_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05454-7","volume":"15","author":"J Cui","year":"2025","unstructured":"Cui, J., Chang, H., Song, Y., Wang, H., & Sun, L. (2025). Exploring the regulatory mechanisms of reproductive dysfunction in obese patients with PCOS. Scientific Reports, 15(1), Article 21669. https:\/\/doi.org\/10.1038\/s41598-025-05454-7","journal-title":"Scientific Reports"},{"key":"11188_CR82","doi-asserted-by":"publisher","unstructured":"Rashid, G., Khan, N. A., Elsori, D., Youness, R. A., Hassan, H., Siwan, D., \u2026 Hafez, W. (2024). miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery. Archives of Gynecology and Obstetrics. https:\/\/doi.org\/10.1007\/s00404-024-07379-4","DOI":"10.1007\/s00404-024-07379-4"},{"key":"11188_CR83","doi-asserted-by":"publisher","unstructured":"Deswal, R., & Dang, A. S. (2020). Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis. Fertility and Sterility, 113(3). https:\/\/doi.org\/10.1016\/j.fertnstert.2019.11.001","DOI":"10.1016\/j.fertnstert.2019.11.001"},{"key":"11188_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/app15052772","author":"V Mladenov","year":"2025","unstructured":"Mladenov, V., Radanova, M., Galcheva, S., & Iotova, V. (2025). Selected microRNAs as potential diagnostic biomarkers in polycystic ovary syndrome in adolescent girls. Applied Sciences. https:\/\/doi.org\/10.3390\/app15052772","journal-title":"Applied Sciences"},{"key":"11188_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00687-9","author":"L Mu","year":"2021","unstructured":"Mu, L., Sun, X., Tu, M., & Zhang, D. (2021). Non-coding RNAs in polycystic ovary syndrome: A systematic review and meta-analysis. Reproductive Biology and Endocrinology. https:\/\/doi.org\/10.1186\/s12958-020-00687-9","journal-title":"Reproductive Biology and Endocrinology"},{"key":"11188_CR86","doi-asserted-by":"publisher","unstructured":"Berenji, E., Valipour Motlagh, A., Fathi, M., Esmaeili, M., Izadi, T., Rezvanian, P., \u2026 Nasr-Esfahani, M. H. (2024). Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data. Scientific Reports, 14(1). https:\/\/doi.org\/10.1038\/s41598-024-56524-1","DOI":"10.1038\/s41598-024-56524-1"},{"issue":"1","key":"11188_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2024.100916","volume":"25","author":"J Li","year":"2024","unstructured":"Li, J., Fan, L., Wei, J., & Huang, W. (2024). Elucidating the pathophysiology of polycystic ovary syndrome: Construction and analysis of a ceRNA network in cumulus cells. Reproductive biology, 25(1), Article 100916. https:\/\/doi.org\/10.1016\/j.repbio.2024.100916","journal-title":"Reproductive biology"},{"key":"11188_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04623-9","author":"C Hou","year":"2025","unstructured":"Hou, C., Zhu, H., & Chang, X. (2025). Mesenchymal stem cells: Opening a new chapter in the treatment of gynecological diseases. Stem Cell Research and Therapy. https:\/\/doi.org\/10.1186\/s13287-025-04623-9","journal-title":"Stem Cell Research and Therapy"},{"key":"11188_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01750-y","author":"R Nair","year":"2025","unstructured":"Nair, R., Agarwal, P., Gadre, M. A., Vasanthan, K. S., & Seetharam, R. N. (2025). Stem cell treatments for female reproductive disorders: A comprehensive review. Journal of Ovarian Research. https:\/\/doi.org\/10.1186\/s13048-025-01750-y","journal-title":"Journal of Ovarian Research"},{"key":"11188_CR90","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X18666230517123256","author":"HR Nejabati","year":"2024","unstructured":"Nejabati, H. R., Nikzad, S., & Roshangar, L. (2024). Therapeutic potential of mesenchymal stem cells in PCOS. Current Stem Cell Research & Therapy. https:\/\/doi.org\/10.2174\/1574888X18666230517123256","journal-title":"Current Stem Cell Research & Therapy"},{"key":"11188_CR91","doi-asserted-by":"publisher","unstructured":"Prayitno, G. D., Lestari, K., Sartika, C. R., Djuwantono, T., Widjaya, A., Muharam, R., \u2026 Zahrah, A. (2022). Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review. Medicines, 10(1). https:\/\/doi.org\/10.3390\/medicines10010003","DOI":"10.3390\/medicines10010003"},{"key":"11188_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1021581","author":"M Izadi","year":"2022","unstructured":"Izadi, M., Rezvani, M. E., Aliabadi, A., Karimi, M., & Aflatoonian, B. (2022). Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndrome. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2022.1021581","journal-title":"Frontiers in Pharmacology"},{"key":"11188_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1269266","author":"M Hadidi","year":"2023","unstructured":"Hadidi, M., Karimabadi, K., Ghanbari, E., Rezakhani, L., & Khazaei, M. (2023). Stem cells and exosomes: As biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2023.1269266","journal-title":"Frontiers in Endocrinology"},{"key":"11188_CR94","doi-asserted-by":"publisher","unstructured":"Khatun, M., Sorjamaa, A., Kangasniemi, M., Sutinen, M., Salo, T., Liakka, A., \u2026 Piltonen, T. T. (2017). Niche matters: The comparison between bone marrow stem cells and endometrial stem cells and stromal fibroblasts reveal distinct migration and cytokine profiles in response to inflammatory stimulus. PLoS ONE, 12(4). https:\/\/doi.org\/10.1371\/journal.pone.0175986","DOI":"10.1371\/journal.pone.0175986"},{"key":"11188_CR95","doi-asserted-by":"publisher","unstructured":"Santamaria, X., Cabanillas, S., Cervell\u00f3, I., Arbona, C., Raga, F., Ferro, J., \u2026 Sim\u00f3n, C. (2016). Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman\u2019s syndrome and endometrial atrophy: A pilot cohort study. Human Reproduction, 31(5). https:\/\/doi.org\/10.1093\/humrep\/dew042","DOI":"10.1093\/humrep\/dew042"},{"key":"11188_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01910-0","author":"J Chen","year":"2025","unstructured":"Chen, J., Zhang, L., Gan, J., Teng, X., Huang, X., Lv, J., & Li, H. (2025). Modulation of PI3K\/AKT\/mTOR signaling pathway by combined stem cell and phytochemical treatment improves metabolic and reproductive outcomes in PCOS. Journal of Ovarian Research. https:\/\/doi.org\/10.1186\/s13048-025-01910-0","journal-title":"Journal of Ovarian Research"},{"key":"11188_CR97","doi-asserted-by":"publisher","unstructured":"Jafarzadeh, H., Nazarian, H., Ghaffari Novin, M., Shams Mofarahe, Z., Eini, F., & Piryaei, A. (2018). Improvement of oocyte in vitro maturation from mice with polycystic ovary syndrome by human mesenchymal stromal cell\u2013conditioned media. Journal of Cellular Biochemistry, 119(12). https:\/\/doi.org\/10.1002\/jcb.27380","DOI":"10.1002\/jcb.27380"},{"key":"11188_CR98","doi-asserted-by":"publisher","unstructured":"Chugh, R. M., Park, H. soo, El Andaloussi, A., Elsharoud, A., Esfandyari, S., Ulin, M., \u2026 Al-Hendy, A. (2021). Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Stem Cell Research and Therapy, 12(1). https:\/\/doi.org\/10.1186\/s13287-021-02472-w","DOI":"10.1186\/s13287-021-02472-w"},{"key":"11188_CR99","doi-asserted-by":"publisher","unstructured":"Park, H. S., Cetin, E., Siblini, H., Seok, J., Alkelani, H., Alkhrait, S., \u2026 Al-Hendy, A. (2023). Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS. International Journal of Molecular Sciences, 24(13). https:\/\/doi.org\/10.3390\/ijms241311151","DOI":"10.3390\/ijms241311151"},{"key":"11188_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179184","author":"RM Chugh","year":"2021","unstructured":"Chugh, R. M., Park, H. S., Esfandyari, S., Elsharoud, A., Ulin, M., & Al-Hendy, A. (2021). Mesenchymal stem cell-conditioned media regulate steroidogenesis and inhibit androgen secretion in a PCOS cell model via BMP-2. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22179184","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"11188_CR101","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13048-024-01445-w","volume":"17","author":"X Teng","year":"2024","unstructured":"Teng, X., Wang, Z., & Wang, X. (2024). Enhancing angiogenesis and inhibiting apoptosis: Evaluating the therapeutic efficacy of bone marrow mesenchymal stem cell-derived exosomes in a DHEA-induced PCOS mouse model. Journal of Ovarian Research, 17(1), 121. https:\/\/doi.org\/10.1186\/s13048-024-01445-w","journal-title":"Journal of Ovarian Research"},{"key":"11188_CR102","doi-asserted-by":"publisher","unstructured":"KALHORI, Z., AZADBAKHT, M., SOLEIMANI MEHRANJANI, M., & SHARIATZADEH, M. A. (2018). Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome. Cytotherapy, 20(12). https:\/\/doi.org\/10.1016\/j.jcyt.2018.09.005","DOI":"10.1016\/j.jcyt.2018.09.005"},{"key":"11188_CR103","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1669619","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y., Tao, M., Wei, M., Du, S., Wang, H., & Wang, X. (2019). Mesenchymal stem cells derived exosomal miR-323\u20133p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS). Artificial Cells, Nanomedicine, and Biotechnology. https:\/\/doi.org\/10.1080\/21691401.2019.1669619","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"11188_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2019.03.484","author":"H Park","year":"2019","unstructured":"Park, H., Ashour, D., Elsharoud, A., Chugh, R., Al-Hendy, A., & El Andaloussi, A. (2019). Towards stem cell therapy of polycystic ovary syndrome (PCOS): Therapeutic effect of human mesenchymal stem cells transplantation in PCOS mouse model by regulating ovarian vascularization. Cytotherapy. https:\/\/doi.org\/10.1016\/j.jcyt.2019.03.484","journal-title":"Cytotherapy"},{"key":"11188_CR105","doi-asserted-by":"publisher","DOI":"10.2174\/1381612829666230816100641","author":"HR Nejabati","year":"2023","unstructured":"Nejabati, H. R., Nikzad, S., & Roshangar, L. (2023). Alleviative effects of adipose tissue-derived stem cells and \u03b1-NETA on metabolic, biochemical, and endocrine parameters in a letrozole-induced rat model of PCOS. Current Pharmaceutical Design. https:\/\/doi.org\/10.2174\/1381612829666230816100641","journal-title":"Current Pharmaceutical Design"},{"key":"11188_CR106","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-023-10505-5","author":"M Karam","year":"2023","unstructured":"Karam, M., Najjar, H., El Sabban, M., Hamade, A., & Najjar, F. (2023). Regenerative medicine for polycystic ovary syndrome: Stem cell-based therapies and brown adipose tissue activation. Stem Cell Reviews and Reports. https:\/\/doi.org\/10.1007\/s12015-023-10505-5","journal-title":"Stem Cell Reviews and Reports"},{"key":"11188_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050848","author":"A Divoux","year":"2022","unstructured":"Divoux, A., Erdos, E., Whytock, K., Osborne, T. F., & Smith, S. R. (2022). Transcriptional and DNA methylation signatures of subcutaneous adipose tissue and adipose-derived stem cells in PCOS women. Cells. https:\/\/doi.org\/10.3390\/cells11050848","journal-title":"Cells"},{"key":"11188_CR108","doi-asserted-by":"publisher","unstructured":"Zhao, H., Shang, Q., Pan, Z., Bai, Y., Li, Z., Zhang, H., \u2026 Wang, Q. (2018). Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes, 67(2). https:\/\/doi.org\/10.2337\/db17-0356","DOI":"10.2337\/db17-0356"},{"key":"11188_CR109","doi-asserted-by":"publisher","unstructured":"Cao, M., Zhao, Y., Chen, T., Zhao, Z., Zhang, B., Yuan, C., \u2026 Zhou, X. (2022). Adipose mesenchymal stem cell\u2013derived exosomal microRNAs ameliorate polycystic ovary syndrome by protecting against metabolic disturbances. Biomaterials, 288. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121739","DOI":"10.1016\/j.biomaterials.2022.121739"},{"key":"11188_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102971","volume":"96","author":"R Naghibzade","year":"2025","unstructured":"Naghibzade, R., Shafiei, G., Nematollahi-Mahani, S. N., Solhjoo, S., & Haghpanah, T. (2025). Improved uterine conditions following ovarian transplantation of adipose-derived mesenchymal stem cell conditioned media in rats with letrozole-induced polycystic ovary syndrome: Histomorphometrical, biochemical, and molecular analysis. Tissue & Cell, 96, Article 102971. https:\/\/doi.org\/10.1016\/j.tice.2025.102971","journal-title":"Tissue & Cell"},{"issue":"3","key":"11188_CR111","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/micmic\/ozad046","volume":"29","author":"SA-E Abd-Elwahab","year":"2023","unstructured":"Abd-Elwahab, S.A.-E., Khamis, N. H., Rifaai, R. A., El-Tahawy, N. F. G., & Ibrahim, R. A. (2023). Mesenchymal-Stem Cell-Derived Conditioned Media Versus Exosomes in the Treatment of Rat Model of Polycystic Ovary: An Attempt to Understand the Underlying Mechanisms (Biochemical and Histological Study). Microscopy and microanalysis\u202f: The official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada, 29(3), 1244\u20131257. https:\/\/doi.org\/10.1093\/micmic\/ozad046","journal-title":"Microscopy and microanalysis : The official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada"},{"issue":"1","key":"11188_CR112","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13048-024-01484-3","volume":"17","author":"M Mansoori","year":"2024","unstructured":"Mansoori, M., Solhjoo, S., Palmerini, M. G., Nematollahi-Mahani, S. N., & Ezzatabadipour, M. (2024). Granulosa cell insight: Unraveling the potential of menstrual blood-derived stem cells and their exosomes on mitochondrial mechanisms in polycystic ovary syndrome (PCOS). Journal of Ovarian Research, 17(1), 167. https:\/\/doi.org\/10.1186\/s13048-024-01484-3","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"11188_CR113","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13048-023-01244-9","volume":"16","author":"AS Roodbari","year":"2023","unstructured":"Roodbari, A. S., Solhjoo, S., Palmerini, M. G., Mansouri, M., & Ezzatabadipour, M. (2023). The effect of human menstrual blood-derived stem cells on ovarian folliculogenesis, angiogenesis and collagen volume in female rats affected by the polycystic ovary syndrome. Journal of Ovarian Research, 16(1), 170. https:\/\/doi.org\/10.1186\/s13048-023-01244-9","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"11188_CR114","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12902-024-01688-0","volume":"24","author":"M Sarvestani","year":"2024","unstructured":"Sarvestani, M., Rajabzadeh, A., Mazoochi, T., Samimi, M., Navari, M., & Moradi, F. (2024). Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome. BMC Endocrine Disorders, 24(1), 154. https:\/\/doi.org\/10.1186\/s12902-024-01688-0","journal-title":"BMC Endocrine Disorders"},{"key":"11188_CR115","doi-asserted-by":"publisher","unstructured":"Cho, J., Kim, T.-H., Seok, J., Jun, J. H., Park, H., Kweon, M., \u2026 Kim, G. J. (2021). Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway. Laboratory Investigation, 101(3), 304\u2013317. https:\/\/doi.org\/10.1038\/s41374-020-00513-1","DOI":"10.1038\/s41374-020-00513-1"},{"key":"11188_CR116","doi-asserted-by":"publisher","unstructured":"Zhao, Y., Pan, S., & Wu, X. (2022). Human umbilical cord mesenchymal stem cell-derived exosomes inhibit ovarian granulosa cells inflammatory response through inhibition of NF-\u03baB signaling in polycystic ovary syndrome. Journal of Reproductive Immunology, 152. https:\/\/doi.org\/10.1016\/j.jri.2022.103638","DOI":"10.1016\/j.jri.2022.103638"},{"key":"11188_CR117","doi-asserted-by":"publisher","unstructured":"Jin, L., Ren, C., Yang, L., Zhu, Y., Li, G., Chang, Y., \u2026 Yuan, Y. (2025). Efficacy and Safety of Human Umbilical Cord Mesenchymal Stem Cells in Improving Fertility in Polycystic Ovary Syndrome Mice. Current stem cell research & therapy, 20(3), 279\u2013290. https:\/\/doi.org\/10.2174\/011574888X287937240424074937","DOI":"10.2174\/011574888X287937240424074937"},{"key":"11188_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-025-01500-7","author":"A Solati","year":"2025","unstructured":"Solati, A., Alaee, S., Zal, F., Khodabandeh, Z., Dara, M., Mehdinejadiani, S., & Bahmyari, S. (2025). Conditioned media and extracellular vesicles derived from human Wharton\u2019s jelly mesenchymal stem cells improve the in vitro maturation of immature oocytes in normal and PCOS mouse model. BioMedical Engineering OnLine. https:\/\/doi.org\/10.1186\/s12938-025-01500-7","journal-title":"BioMedical Engineering OnLine"},{"key":"11188_CR119","doi-asserted-by":"publisher","unstructured":"Ding, K., Wang, X., Liu, W., Chen, Y., Xue, F., Song, C., \u2026 Li, J. (2025). Engineering modification of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorates polycystic ovary syndrome by enhancing the ovarian environment and regulating follicular development. Stem Cell Research & Therapy, 16(1), 481. https:\/\/doi.org\/10.1186\/s13287-025-04610-0","DOI":"10.1186\/s13287-025-04610-0"},{"key":"11188_CR120","doi-asserted-by":"publisher","unstructured":"Xie, Q., Xiong, X., Xiao, N., He, K., Chen, M., Peng, J., \u2026 Cheng, L. (2019). Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells International, 2019. https:\/\/doi.org\/10.1155\/2019\/9782373","DOI":"10.1155\/2019\/9782373"},{"issue":"3","key":"11188_CR121","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/cpr.12258","volume":"49","author":"S Yang","year":"2016","unstructured":"Yang, S., Ding, S., Jiang, X., Sun, B., & Xu, Q. (2016). Establishment and adipocyte differentiation of polycystic ovary syndrome-derived induced pluripotent stem cells. Cell Proliferation, 49(3), 352\u2013361. https:\/\/doi.org\/10.1111\/cpr.12258","journal-title":"Cell Proliferation"},{"key":"11188_CR122","doi-asserted-by":"publisher","unstructured":"Min, Z., Gao, Q., Zhen, X., Fan, Y., Tan, T., Li, R., \u2026 Yu, Y. (2018). New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women. Stem Cell Research & Therapy, 9(1), 210. https:\/\/doi.org\/10.1186\/s13287-018-0950-x","DOI":"10.1186\/s13287-018-0950-x"},{"issue":"3","key":"11188_CR123","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.fertnstert.2019.05.004","volume":"112","author":"C-C Huang","year":"2019","unstructured":"Huang, C.-C., Chen, M.-J., Lan, C.-W., Wu, C.-E., Huang, M.-C., Kuo, H.-C., & Ho, H.-N. (2019). Hyperactive CREB signaling pathway involved in the pathogenesis of polycystic ovarian syndrome revealed by patient-specific induced pluripotent stem cell modeling. Fertility and Sterility, 112(3), 594-607.e12. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.05.004","journal-title":"Fertility and Sterility"},{"issue":"7","key":"11188_CR124","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s13238-018-0600-1","volume":"10","author":"Z Min","year":"2019","unstructured":"Min, Z., Zhao, Y., Hang, J., Ren, Y., Tan, T., Fan, Y., & Yu, Y. (2019). Neuroendocrine characteristics of induced pluripotent stem cells from polycystic ovary syndrome women. Protein & Cell, 10(7), 526\u2013532. https:\/\/doi.org\/10.1007\/s13238-018-0600-1","journal-title":"Protein & Cell"},{"key":"11188_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.57","author":"R Azziz","year":"2017","unstructured":"Azziz, R. (2017). PCOS: Animal models for PCOS-not the real thing. Nature Reviews Endocrinology. https:\/\/doi.org\/10.1038\/nrendo.2017.57","journal-title":"Nature Reviews Endocrinology"},{"issue":"12","key":"11188_CR126","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac164","volume":"163","author":"E Stener-Victorin","year":"2022","unstructured":"Stener-Victorin, E. (2022). Update on animal models of polycystic ovary syndrome. Endocrinology, 163(12), Article bqac164. https:\/\/doi.org\/10.1210\/endocr\/bqac164","journal-title":"Endocrinology"},{"key":"11188_CR127","doi-asserted-by":"publisher","unstructured":"Frey-Vasconcells, J., Whittlesey, K. J., Baum, E., & Feigal, E. G. (2012). Translation of Stem Cell Research: Points to Consider in Designing Preclinical Animal Studies. Stem Cells Translational Medicine, 1(5). https:\/\/doi.org\/10.5966\/sctm.2012-0018","DOI":"10.5966\/sctm.2012-0018"},{"key":"11188_CR128","doi-asserted-by":"publisher","unstructured":"Hladik, D., H\u00f6fig, I., Oestreicher, U., Beckers, J., Matjanovski, M., Bao, X., \u2026 Rosemann, M. (2019). Long-term culture of mesenchymal stem cells impairs ATM-dependent recognition of DNA breaks and increases genetic instability. Stem Cell Research and Therapy, 10(1). https:\/\/doi.org\/10.1186\/s13287-019-1334-6","DOI":"10.1186\/s13287-019-1334-6"},{"key":"11188_CR129","doi-asserted-by":"publisher","unstructured":"Chen, S., Zhang, L., Ren, Y., Bai, X., Wei, X., Chai, M., \u2026 Deng, H. (2026). Clinical translational research on stem cell products: prospects and challenges. Signal Transduction and Targeted Therapy, 11(1), 178. https:\/\/doi.org\/10.1038\/s41392-026-02582-y","DOI":"10.1038\/s41392-026-02582-y"},{"key":"11188_CR130","doi-asserted-by":"publisher","unstructured":"Doudna, J. A., & Charpentier, E. (2014). Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (New York, N.Y.), 346(6213), 1258096. https:\/\/doi.org\/10.1126\/science.1258096","DOI":"10.1126\/science.1258096"},{"key":"11188_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.01.042","author":"M Pacesa","year":"2024","unstructured":"Pacesa, M., Pelea, O., & Jinek, M. (2024). Past, present, and future of CRISPR genome editing technologies. Cell. https:\/\/doi.org\/10.1016\/j.cell.2024.01.042","journal-title":"Cell"},{"key":"11188_CR132","doi-asserted-by":"publisher","unstructured":"Subica, A. M. (2023). CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications. American Journal of Public Health, 113(8). https:\/\/doi.org\/10.2105\/AJPH.2023.307315","DOI":"10.2105\/AJPH.2023.307315"},{"key":"11188_CR133","doi-asserted-by":"publisher","unstructured":"Palacios-Gonz\u00e1lez, C. (2021). Reproductive genome editing interventions are therapeutic, sometimes. Bioethics, 35(6). https:\/\/doi.org\/10.1111\/bioe.12846","DOI":"10.1111\/bioe.12846"},{"key":"11188_CR134","doi-asserted-by":"publisher","unstructured":"Liu, Z., Dai, L., Sun, T., Liu, Y., Bao, Y., Gu, M., \u2026 Zhang, W. (2024). Massively Parallel CRISPR-Cas9 Knockout Screening in Sheep Granulosa Cells for FSH Response Genes. Animals, 14(6). https:\/\/doi.org\/10.3390\/ani14060898","DOI":"10.3390\/ani14060898"},{"key":"11188_CR135","doi-asserted-by":"publisher","unstructured":"Guller, A. S., Sahin Kayabolen, G. N., Soyler, G., Comar, M. Y., Yilmaz Duzgun, I., Sivaslioglu, A., & Karahuseyinoglu, S. (2023). O-104 The Impact of application of CRISPR \/dCas9 systems for increasing the expression of FSH receptor in human granulosa cells. Human Reproduction, 38(Supplement_1). https:\/\/doi.org\/10.1093\/humrep\/dead093.127","DOI":"10.1093\/humrep\/dead093.127"},{"key":"11188_CR136","doi-asserted-by":"publisher","unstructured":"Cheung, V. C., Peng, C. Y., Marini\u0107, M., Sakabe, N. J., Aneas, I., Lynch, V. J., \u2026 Kessler, J. A. (2021). Pluripotent stem cell-derived endometrial stromal fibroblasts in a cyclic, hormone-responsive, coculture model of human decidua. Cell Reports, 35(7). https:\/\/doi.org\/10.1016\/j.celrep.2021.109138","DOI":"10.1016\/j.celrep.2021.109138"},{"key":"11188_CR137","doi-asserted-by":"publisher","unstructured":"Miyazaki, K., Dyson, M. T., Coon V, J. S., Furukawa, Y., Yilmaz, B. D., Maruyama, T., & Bulun, S. E. (2018). Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT\/CTNNB1 Pathway. Stem Cell Reports, 11(5). https:\/\/doi.org\/10.1016\/j.stemcr.2018.10.002","DOI":"10.1016\/j.stemcr.2018.10.002"},{"key":"11188_CR138","doi-asserted-by":"publisher","unstructured":"Palumbo, M., Della Corte, L., Colacurci, D., Ascione, M., D\u2019Angelo, G., Baldini, G. M., \u2026 Bifulco, G. (2025). PCOS and the Genome: Is the Genetic Puzzle Still Worth Solving? Biomedicines, 13(8). https:\/\/doi.org\/10.3390\/biomedicines13081912","DOI":"10.3390\/biomedicines13081912"},{"key":"11188_CR139","doi-asserted-by":"publisher","unstructured":"Tan, M., Cheng, Y., Zhong, X., Yang, D., Jiang, S., Ye, Y., \u2026 Zhao, X. (2021). LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway. Aging, 13(3). https:\/\/doi.org\/10.18632\/aging.202421","DOI":"10.18632\/aging.202421"},{"key":"11188_CR140","doi-asserted-by":"publisher","unstructured":"Han, S., Zhang, Y., Zheng, Y., Liu, C., Jiang, Y., Zhao, S., & Zhao, H. (2022). Thada Is Dispensable for Female Fertility in Mice. Frontiers in Endocrinology, 13. https:\/\/doi.org\/10.3389\/fendo.2022.787733","DOI":"10.3389\/fendo.2022.787733"},{"key":"11188_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2025.112639","volume":"608","author":"L Chen","year":"2025","unstructured":"Chen, L., Hui, L., Shi, Y., Wang, A., Zhang, Y., Yao, X., & Li, J. (2025). The role of IGFBP7 in the immune regulation of PCOS-like symptoms based on spleen transcriptome and TCR \u03b2 CDR3 repertoire analysis. Molecular and Cellular Endocrinology, 608, Article 112639. https:\/\/doi.org\/10.1016\/j.mce.2025.112639","journal-title":"Molecular and Cellular Endocrinology"},{"key":"11188_CR142","doi-asserted-by":"publisher","unstructured":"Sankaranarayanan, L., Brewer, K. J., Johnson, G. D., Barrera, A., Venukuttan, R., Sisk, R., \u2026 Reddy, T. E. (2024). Gene regulatory activity associated with PCOS revealed DENND1-dependent testosterone production. bioRxiv, 2024.05.23.595551. https:\/\/doi.org\/10.1101\/2024.05.23.595551","DOI":"10.1101\/2024.05.23.595551"},{"issue":"1","key":"11188_CR143","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41556-020-00620-7","volume":"23","author":"M Nakamura","year":"2021","unstructured":"Nakamura, M., Gao, Y., Dominguez, A. A., & Qi, L. S. (2021). CRISPR technologies for precise epigenome editing. Nature Cell Biology, 23(1), 11\u201322. https:\/\/doi.org\/10.1038\/s41556-020-00620-7","journal-title":"Nature Cell Biology"},{"key":"11188_CR144","doi-asserted-by":"publisher","unstructured":"Zhong, X., Jin, F., Huang, C., Du, M., Gao, M., & Wei, X. (2021). DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS). In Technology and Health Care (Vol. 29). https:\/\/doi.org\/10.3233\/THC-218002","DOI":"10.3233\/THC-218002"},{"key":"11188_CR145","doi-asserted-by":"publisher","unstructured":"Cao, P., Yang, W., Wang, P., Li, X., & Nashun, B. (2021). Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome. Frontiers in Cell and Developmental Biology, 9. https:\/\/doi.org\/10.3389\/fcell.2021.664843","DOI":"10.3389\/fcell.2021.664843"},{"key":"11188_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2023.10.004","author":"Y Gao","year":"2024","unstructured":"Gao, Y., Guo, L., Wang, F., Wang, Y., Li, P., & Zhang, D. (2024). Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: A review. Cytotherapy. https:\/\/doi.org\/10.1016\/j.jcyt.2023.10.004","journal-title":"Cytotherapy"},{"key":"11188_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108524","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y., Wang, H., & Li, M. (2023). The promise of CRISPR\/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment. Journal of Diabetes and Its Complications. https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108524","journal-title":"Journal of Diabetes and Its Complications"},{"key":"11188_CR148","doi-asserted-by":"publisher","unstructured":"Panda, S. P., Kesharwani, A., Singh, G. D., Prasanth, D., Vatchavai, B. R., Kumari, P. V. K., \u2026 Mallick, S. P. (2023). Impose of KNDy\/GnRH neural circuit in PCOS, ageing, cancer and Alzheimer\u2019s disease: StAR actions in prevention of neuroendocrine dysfunction. Ageing Research Reviews. https:\/\/doi.org\/10.1016\/j.arr.2023.102086","DOI":"10.1016\/j.arr.2023.102086"},{"key":"11188_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2020.04.005","author":"CR McCartney","year":"2020","unstructured":"McCartney, C. R., & Campbell, R. E. (2020). Abnormal GnRH pulsatility in polycystic ovary syndrome: Recent insights. Current Opinion in Endocrine and Metabolic Research. https:\/\/doi.org\/10.1016\/j.coemr.2020.04.005","journal-title":"Current Opinion in Endocrine and Metabolic Research"},{"key":"11188_CR150","doi-asserted-by":"publisher","unstructured":"Boender, A. J., Boon, M., Elliott Albers, H., Eck, S. R., Fricker, B. A., Kelly, A. M., \u2026 Young, L. J. (2023). An AAV-CRISPR\/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept. Science Advances, 9(22). https:\/\/doi.org\/10.1126\/sciadv.adf4950","DOI":"10.1126\/sciadv.adf4950"},{"key":"11188_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020324","author":"M Deutsch","year":"2021","unstructured":"Deutsch, M., G\u00fcnther, A., Lerchundi, R., Rose, C. R., Balfanz, S., & Baumann, A. (2021). AAV-mediated CRISPRi and RNAi based gene silencing in mouse hippocampal neurons. Cells. https:\/\/doi.org\/10.3390\/cells10020324","journal-title":"Cells"},{"key":"11188_CR152","doi-asserted-by":"publisher","unstructured":"Silva, M. S. B., Decoster, L., Delpouve, G., Lhomme, T., Ternier, G., Prevot, V., & Giacobini, P. (2023). Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice. eBioMedicine, 97. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104850","DOI":"10.1016\/j.ebiom.2023.104850"},{"key":"11188_CR153","doi-asserted-by":"publisher","unstructured":"Fl\u00f3rez, J. M., Martins, K., Solin, S., Bostrom, J. R., Rodr\u00edguez-Villamil, P., Ongaratto, F., \u2026 Lents, C. A. (2023). CRISPR\/Cas9-editing of KISS1 to generate pigs with hypogonadotropic hypogonadism as a castration free trait. Frontiers in Genetics, 13. https:\/\/doi.org\/10.3389\/fgene.2022.1078991","DOI":"10.3389\/fgene.2022.1078991"},{"key":"11188_CR154","doi-asserted-by":"publisher","unstructured":"Qiao, S., Alasmi, S., Wyatt, A., Wartenberg, P., Wang, H., Candlish, M., \u2026 Boehm, U. (2023). Intra-pituitary follicle-stimulating hormone signaling regulates hepatic lipid metabolism in mice. Nature Communications, 14(1). https:\/\/doi.org\/10.1038\/s41467-023-36681-z","DOI":"10.1038\/s41467-023-36681-z"},{"key":"11188_CR155","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70000","author":"IT Huhtaniemi","year":"2025","unstructured":"Huhtaniemi, I. T. (2025). Luteinizing hormone receptor knockout mouse: What has it taught us? Andrology. https:\/\/doi.org\/10.1111\/andr.70000","journal-title":"Andrology"},{"issue":"1","key":"11188_CR156","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12958-025-01359-2","volume":"23","author":"A Conforti","year":"2025","unstructured":"Conforti, A., Di Girolamo, R., Guida, M., Alviggi, C., & Casarini, L. (2025). Pharmacogenomic of LH and its receptor: Are we ready for clinical practice? Reproductive Biology and Endocrinology, 23(1), 29. https:\/\/doi.org\/10.1186\/s12958-025-01359-2","journal-title":"Reproductive Biology and Endocrinology"},{"key":"11188_CR157","doi-asserted-by":"publisher","unstructured":"Teves, M. E., Modi, B. P., Kulkarni, R., Han, A. X., Marks, J. S., Subler, M. A., \u2026 Strauss, J. F. (2020). Human dennd1a.V2 drives cyp17a1 expression and androgen production in mouse ovaries and adrenals. International Journal of Molecular Sciences, 21(7). https:\/\/doi.org\/10.3390\/ijms21072545","DOI":"10.3390\/ijms21072545"},{"key":"11188_CR158","doi-asserted-by":"publisher","unstructured":"Bourgneuf, C., Bailb\u00e9, D., Lamazi\u00e8re, A., Dupont, C., Moldes, M., Farabos, D., \u2026 Racine, C. (2021). The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nature Communications, 12(1). https:\/\/doi.org\/10.1038\/s41467-021-21308-y","DOI":"10.1038\/s41467-021-21308-y"},{"key":"11188_CR159","doi-asserted-by":"publisher","unstructured":"Mukhare, R., Gandhi, K. A., Kadam, A., Raja, A., Singh, A., Madhav, M., \u2026 Gupta, S. (2025). Integration of Organoids With CRISPR Screens: A Narrative Review. Biology of the cell, 117(4), e70006. https:\/\/doi.org\/10.1111\/boc.70006","DOI":"10.1111\/boc.70006"},{"key":"11188_CR160","doi-asserted-by":"publisher","unstructured":"Luyckx, L., Wei, M., Saarela, U., Myllykangas, M., Kinnunen, J., Arffman, R., \u2026 Piltonen, T. T. (2025). PCOS endometrium-derived epithelial organoids as a novel model to study endometrial dysfunction. Human Reproduction, deaf113. https:\/\/doi.org\/10.1093\/humrep\/deaf113","DOI":"10.1093\/humrep\/deaf113"},{"key":"11188_CR161","doi-asserted-by":"publisher","unstructured":"Wiwatpanit, T., Murphy, A. R., Lu, Z., Urbanek, M., Burdette, J. E., Woodruff, T. K., & Kim, J. J. (2020). Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome. Journal of Clinical Endocrinology and Metabolism, 105(3). https:\/\/doi.org\/10.1210\/clinem\/dgz100","DOI":"10.1210\/clinem\/dgz100"},{"key":"11188_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.diff.2017.11.004","author":"S Kuokkanen","year":"2017","unstructured":"Kuokkanen, S., Zhu, L., & Pollard, J. W. (2017). Xenografted tissue models for the study of human endometrial biology. Differentiation. https:\/\/doi.org\/10.1016\/j.diff.2017.11.004","journal-title":"Differentiation"},{"issue":"1","key":"11188_CR163","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12951-024-02651-w","volume":"22","author":"Z-M Deng","year":"2024","unstructured":"Deng, Z.-M., Dai, F.-F., Wang, R.-Q., Deng, H.-B., Yin, T.-L., Cheng, Y.-X., & Chen, G.-T. (2024). Organ-on-a-chip: Future of female reproductive pathophysiological models. Journal of Nanobiotechnology, 22(1), 455. https:\/\/doi.org\/10.1186\/s12951-024-02651-w","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"11188_CR164","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s44222-022-00013-5","volume":"1","author":"MH Geurts","year":"2023","unstructured":"Geurts, M. H., & Clevers, H. (2023). CRISPR engineering in organoids for gene repair and disease modelling. Nature Reviews Bioengineering, 1(1), 32\u201345. https:\/\/doi.org\/10.1038\/s44222-022-00013-5","journal-title":"Nature Reviews Bioengineering"},{"issue":"10","key":"11188_CR165","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s43032-025-01972-x","volume":"32","author":"N Kumar","year":"2025","unstructured":"Kumar, N. (2025). Genome editing for fertility: Unlocking the promise of CRISPR\/Cas9 in addressing male infertility \u2013 A narrative review. Reproductive Sciences, 32(10), 3221\u20133239. https:\/\/doi.org\/10.1007\/s43032-025-01972-x","journal-title":"Reproductive Sciences"},{"key":"11188_CR166","doi-asserted-by":"publisher","unstructured":"Wang, L., Xiong, D., Yan, H., Long, F., Zhang, G., Zeng, J., \u2026 Liu, W. (2025). MMP-9 dysregulation and chronic inflammation in polycystic ovary syndrome: linking ovulatory dysfunction to diagnostic implications. Journal of Ovarian Research, 18(1), 247. https:\/\/doi.org\/10.1186\/s13048-025-01851-8","DOI":"10.1186\/s13048-025-01851-8"},{"key":"11188_CR167","doi-asserted-by":"publisher","unstructured":"Prithiviraj, S., Garcia Garcia, A., Linderfalk, K., Yiguang, B., Ferveur, S., Falck, L. N., \u2026 Bourgine, P. E. (2025). Compositional editing of extracellular matrices by CRISPR\/Cas9 engineering of human mesenchymal stem cell lines. eLife, 13. https:\/\/doi.org\/10.7554\/eLife.96941","DOI":"10.7554\/eLife.96941"},{"key":"11188_CR168","doi-asserted-by":"publisher","unstructured":"Escalona, R. M., Chu, S., Kadife, E., Kelly, J. K., Kannourakis, G., Findlay, J. K., & Ahmed, N. (2022). Knock down of TIMP-2 by siRNA and CRISPR\/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer. Cancer Cell International, 22(1). https:\/\/doi.org\/10.1186\/s12935-022-02838-x","DOI":"10.1186\/s12935-022-02838-x"},{"key":"11188_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.106968","author":"AF Leal","year":"2023","unstructured":"Leal, A. F., Fnu, N., Benincore-Fl\u00f3rez, E., Herre\u00f1o-Pach\u00f3n, A. M., Echeverri-Pe\u00f1a, O. Y., Alm\u00e9ciga-D\u00edaz, C. J., & Tomatsu, S. (2023). The landscape of CRISPR\/Cas9 for inborn errors of metabolism. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2022.106968","journal-title":"Molecular Genetics and Metabolism"},{"key":"11188_CR170","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15240","author":"M Lotfi","year":"2024","unstructured":"Lotfi, M., Butler, A. E., Sukhorukov, V. N., & Sahebkar, A. (2024). Application of CRISPR-Cas9 technology in diabetes research. Diabetic Medicine. https:\/\/doi.org\/10.1111\/dme.15240","journal-title":"Diabetic Medicine"},{"key":"11188_CR171","doi-asserted-by":"publisher","unstructured":"Hirose, M., Inoue, K., Matoba, S., Tatebe, T., Tokita, S., Dodo, Y., \u2026 Ogura, A. (2024). Disruption of insulin receptor substrate 2 (IRS2) causes non-obese type 2 diabetes with \u03b2-cell dysfunction in the golden (Syrian) hamster. Scientific reports, 14(1), 17450. https:\/\/doi.org\/10.1038\/s41598-024-67513-9","DOI":"10.1038\/s41598-024-67513-9"},{"key":"11188_CR172","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2014-0114","author":"JM Oliveira","year":"2014","unstructured":"Oliveira, J. M., Rebuffat, S. A., Gasa, R., & Gomis, R. (2014). Targeting type 2 diabetes: Lessons from a knockout model of insulin receptor substrate 2. Canadian Journal of Physiology and Pharmacology. https:\/\/doi.org\/10.1139\/cjpp-2014-0114","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"11188_CR173","doi-asserted-by":"publisher","unstructured":"Kido, Y., Burks, D. J., Withers, D., Bruning, J. C., Kahn, C. R., White, M. F., & Accili, D. (2000). Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. Journal of Clinical Investigation, 105(2). https:\/\/doi.org\/10.1172\/JCI7917","DOI":"10.1172\/JCI7917"},{"key":"11188_CR174","doi-asserted-by":"publisher","unstructured":"Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., \u2026 Kadowaki, T. (2000). Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory \u03b2-cell hyperplasia. Diabetes, 49(11). https:\/\/doi.org\/10.2337\/diabetes.49.11.1880","DOI":"10.2337\/diabetes.49.11.1880"},{"key":"11188_CR175","doi-asserted-by":"publisher","unstructured":"Matboli, M., Kamel, M. M., Essawy, N., Bekhit, M. M., Abdulrahman, B., Mohamed, G. F., & Eissa, S. (2021). Article identification of novel insulin resistance related cerna network in t2dm and its potential editing by crispr\/cas9. International Journal of Molecular Sciences, 22(15). https:\/\/doi.org\/10.3390\/ijms22158129","DOI":"10.3390\/ijms22158129"},{"key":"11188_CR176","doi-asserted-by":"publisher","unstructured":"Ali, H. S., Kamel, M. M., Agwa, S. H. A., Hakeem, M. S. A., Meteini, M. S. El, & Matboli, M. (2023). Analysis of mRNA-miRNA-lncRNA differential expression in prediabetes\/type 2 diabetes mellitus patients as potential players in insulin resistance. Frontiers in Endocrinology, 14. https:\/\/doi.org\/10.3389\/fendo.2023.1131171","DOI":"10.3389\/fendo.2023.1131171"},{"key":"11188_CR177","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7781823","author":"Z Shaaban","year":"2021","unstructured":"Shaaban, Z., Khoradmehr, A., Amiri-Yekta, A., Nowzari, F., Jafarzadeh Shirazi, M. R., & Tamadon, A. (2021). Pathophysiologic mechanisms of insulin secretion and signaling-related genes in etiology of polycystic ovary syndrome. Genetics Research. https:\/\/doi.org\/10.1155\/2021\/7781823","journal-title":"Genetics Research"},{"key":"11188_CR178","doi-asserted-by":"publisher","unstructured":"Kamble, P. G., Hetty, S., Vranic, M., Almby, K., Castillejo-L\u00f3pez, C., Abalo, X. M., \u2026 Eriksson, J. W. (2020). Proof-of-concept for CRISPR\/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism. Scientific reports, 10(1), 10565. https:\/\/doi.org\/10.1038\/s41598-020-67293-y","DOI":"10.1038\/s41598-020-67293-y"},{"key":"11188_CR179","doi-asserted-by":"publisher","unstructured":"Zhu, H., Liu, D., Sui, M., Zhou, M., Wang, B., Qi, Q., \u2026 Zhang, B. (2023). CRISPRa\u2010based activation of Fgf21 and Fndc5 ameliorates obesity by promoting adipocytes browning . Clinical and Translational Medicine, 13(7). https:\/\/doi.org\/10.1002\/ctm2.1326","DOI":"10.1002\/ctm2.1326"},{"key":"11188_CR180","doi-asserted-by":"publisher","unstructured":"Tsagkaraki, E., Guilherme, A., Nicoloro, S. M., Kelly, M., Lifshitz, L. M., Wang, H., \u2026 Czech, M. P. (2023). Crosstalk between corepressor NRIP1 and cAMP signaling on adipocyte thermogenic programming. Molecular Metabolism, 76. https:\/\/doi.org\/10.1016\/j.molmet.2023.101780","DOI":"10.1016\/j.molmet.2023.101780"},{"key":"11188_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115257","volume":"163","author":"O Eladl","year":"2025","unstructured":"Eladl, O. (2025). CRISPR interference-mediated silencing of pro-inflammatory genes in autoimmune models: Functional and biophysical evaluation with sustained effects in primary human PBMCs. International Immunopharmacology, 163, Article 115257. https:\/\/doi.org\/10.1016\/j.intimp.2025.115257","journal-title":"International Immunopharmacology"},{"key":"11188_CR182","doi-asserted-by":"publisher","unstructured":"Valc\u00e1rcel, G., Lazarenkov, A., L\u00f3pez-Rubio, A. V., Berenguer, C., Calafell-Segura, J., Rodr\u00edguez-Ubreva, J., \u2026 Sardina, J. L. (2025). Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing. Science Advances , 11(29). https:\/\/doi.org\/10.1126\/sciadv.adt1644","DOI":"10.1126\/sciadv.adt1644"},{"key":"11188_CR183","doi-asserted-by":"publisher","unstructured":"Farhang, N., Brunger, J. M., Stover, J. D., Thakore, P. I., Lawrence, B., Guilak, F., \u2026 Bowles, R. D. (2017). CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments. Tissue Engineering - Part A, 23(15\u201316). https:\/\/doi.org\/10.1089\/ten.tea.2016.0441","DOI":"10.1089\/ten.tea.2016.0441"},{"key":"11188_CR184","doi-asserted-by":"publisher","unstructured":"Conti, A., Giannetti, K., Midena, F., Beretta, S., Gualandi, N., De Marco, R., \u2026 Di Micco, R. (2025). Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9\/AAV6-mediated gene editing in hematopoietic stem cells. Cell Reports Medicine, 6(6). https:\/\/doi.org\/10.1016\/j.xcrm.2025.102157","DOI":"10.1016\/j.xcrm.2025.102157"},{"key":"11188_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00802-4","author":"X Bai","year":"2021","unstructured":"Bai, X., Zheng, L., Li, D., & Xu, Y. (2021). Research progress of endometrial receptivity in patients with polycystic ovary syndrome: A systematic review. Reproductive Biology and Endocrinology. https:\/\/doi.org\/10.1186\/s12958-021-00802-4","journal-title":"Reproductive Biology and Endocrinology"},{"key":"11188_CR186","doi-asserted-by":"publisher","unstructured":"Lavogina, D., Stepanjuk, A., Peters, M., Samuel, K., Kasvandik, S., Khatun, M., \u2026 Salumets, A. (2021). Progesterone triggers Rho kinase-cofilin axis during in vitro and in vivo endometrial decidualization. Human reproduction (Oxford, England), 36(8). https:\/\/doi.org\/10.1093\/humrep\/deab161","DOI":"10.1093\/humrep\/deab161"},{"key":"11188_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021203","author":"S Matsuyama","year":"2024","unstructured":"Matsuyama, S., Whiteside, S., & Li, S. Y. (2024). Implantation and decidualization in PCOS: Unraveling the complexities of pregnancy. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms25021203","journal-title":"International Journal of Molecular Sciences"},{"key":"11188_CR188","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-022-09353-1","author":"J Li","year":"2022","unstructured":"Li, J., Jiang, X., Li, C., Che, H., Ling, L., & Wei, Z. (2022). Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity. Clinical Proteomics. https:\/\/doi.org\/10.1186\/s12014-022-09353-1","journal-title":"Clinical Proteomics"},{"key":"11188_CR189","doi-asserted-by":"publisher","unstructured":"Wang, H., Tang, Z., Li, T., Liu, M., Li, Y., & Xing, B. (2019). CRISPR\/Cas9-mediated gene knockout of ARID1A promotes primary progesterone resistance by downregulating progesterone receptor B in endometrial cancer cells. Oncology Research, 27(9). https:\/\/doi.org\/10.3727\/096504019X15561873320465","DOI":"10.3727\/096504019X15561873320465"},{"key":"11188_CR190","doi-asserted-by":"publisher","unstructured":"Khatun, M., Modhukur, V., Piltonen, T. T., Tapanainen, J. S., & Salumets, A. (2024). Stanniocalcin Protein Expression in Female Reproductive Organs: Literature Review and Public Cancer Database Analysis. Endocrinology, 165(10), bqae110. https:\/\/doi.org\/10.1210\/endocr\/bqae110","DOI":"10.1210\/endocr\/bqae110"},{"key":"11188_CR191","doi-asserted-by":"publisher","unstructured":"Khatun, M., Urpilainen, E., Ahtikoski, A., Arffman, R. K., Pasanen, A., Puistola, U., \u2026 Piltonen, T. T. (2021). Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer. Pathology and Oncology Research, 27. https:\/\/doi.org\/10.3389\/pore.2021.1609936","DOI":"10.3389\/pore.2021.1609936"},{"key":"11188_CR192","doi-asserted-by":"publisher","unstructured":"Meltsov, A., Saare, M., Teder, H., Paluoja, P., Arffman, R. K., Piltonen, T., \u2026 Palta, P. (2023). Targeted gene expression profiling for accurate endometrial receptivity testing. Scientific Reports, 13(1). https:\/\/doi.org\/10.1038\/s41598-023-40991-z","DOI":"10.1038\/s41598-023-40991-z"},{"key":"11188_CR193","doi-asserted-by":"publisher","unstructured":"de Oliveira, V. C., Roballo, K. C. S., Mariano Junior, C. G., & Ambr\u00f3sio, C. E. (2023). Gene Editing Technologies Targeting TFAM and Its Relation to Mitochondrial Diseases. In G. A. Passos (Ed.), Genome editing in biomedical sciences (pp. 173\u2013189). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-031-33325-5_10","DOI":"10.1007\/978-3-031-33325-5_10"},{"issue":"1","key":"11188_CR194","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-024-02081-y","volume":"10","author":"M Li","year":"2025","unstructured":"Li, M., Wu, L., Si, H., Wu, Y., Liu, Y., Zeng, Y., & Shen, B. (2025). Engineered mitochondria in diseases: Mechanisms, strategies, and applications. Signal Transduction and Targeted Therapy, 10(1), 71. https:\/\/doi.org\/10.1038\/s41392-024-02081-y","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11188_CR195","doi-asserted-by":"publisher","unstructured":"Kobayashi, H., Matsubara, S., Yoshimoto, C., Shigetomi, H., & Imanaka, S. (2025). A Comprehensive Review of the Contribution of Mitochondrial DNA Mutations and Dysfunction in Polycystic Ovary Syndrome, Supported by Secondary Database Analysis. International Journal of Molecular Sciences, 26(3). https:\/\/doi.org\/10.3390\/ijms26031172","DOI":"10.3390\/ijms26031172"},{"key":"11188_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103776","volume":"85","author":"H Liu","year":"2025","unstructured":"Liu, H., Jin, L., Wang, X., Shi, J., He, Y., Sun, N., & Yang, F. (2025). Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities. Redox biology, 85, Article 103776. https:\/\/doi.org\/10.1016\/j.redox.2025.103776","journal-title":"Redox biology"},{"issue":"5","key":"11188_CR197","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s12015-025-10887-8","volume":"21","author":"Q Zhao","year":"2025","unstructured":"Zhao, Q., Shao, M., Ma, L., & Zhou, R. (2025). Insights into modeling inflammatory bowel disease from stem cell derived intestinal organoids. Stem Cell Reviews and Reports, 21(5), 1351\u20131368. https:\/\/doi.org\/10.1007\/s12015-025-10887-8","journal-title":"Stem Cell Reviews and Reports"},{"issue":"1","key":"11188_CR198","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13048-025-01648-9","volume":"18","author":"F Esfandiarinezhad","year":"2025","unstructured":"Esfandiarinezhad, F., Zhan, X., Tan, S. L., Li, J., & Tsang, B. K. (2025). A primary insight into gut microbiome, MicroRNA and stemness, in a PCOS rat model. Journal of ovarian research, 18(1), 66. https:\/\/doi.org\/10.1186\/s13048-025-01648-9","journal-title":"Journal of ovarian research"},{"key":"11188_CR199","doi-asserted-by":"publisher","unstructured":"Wang, L., Zhou, J., Gober, H. J., Leung, W. T., Huang, Z., Pan, X., \u2026 Wang, L. (2021). Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomedicine and Pharmacotherapy. https:\/\/doi.org\/10.1016\/j.biopha.2020.110958","DOI":"10.1016\/j.biopha.2020.110958"},{"issue":"9","key":"11188_CR200","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00510-24","volume":"93","author":"M Echavarria Galindo","year":"2025","unstructured":"Echavarria Galindo, M., & Lai, Y. (2025). CRISPR-based genetic tools for the study of host-microbe interactions. Infection and Immunity, 93(9), Article e0051024. https:\/\/doi.org\/10.1128\/iai.00510-24","journal-title":"Infection and Immunity"},{"key":"11188_CR201","doi-asserted-by":"publisher","unstructured":"Liu, X., Wei, Q., Lu, L., Cui, S., Ma, K., Zhang, W., \u2026 Zhang, C. (2023). Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2023.1094685","DOI":"10.3389\/fimmu.2023.1094685"},{"key":"11188_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591065","author":"S Dabrowska","year":"2021","unstructured":"Dabrowska, S., Andrzejewska, A., Janowski, M., & Lukomska, B. (2021). Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: Therapeutic outlook for inflammatory and degenerative diseases. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2020.591065","journal-title":"Frontiers in Immunology"},{"key":"11188_CR203","doi-asserted-by":"publisher","unstructured":"Rashid, R., Mir, S. A., Kareem, O., Ali, T., Ara, R., Malik, A., \u2026 Bader, G. N. (2022). Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwanese Journal of Obstetrics and Gynecology. https:\/\/doi.org\/10.1016\/j.tjog.2021.11.009","DOI":"10.1016\/j.tjog.2021.11.009"},{"key":"11188_CR204","doi-asserted-by":"publisher","unstructured":"Kim, M., Hwang, Y., Lim, S., Jang, H.-K., & Kim, H.-O. (2024). Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR\/Cas9. Pharmaceutics, 16(9). https:\/\/doi.org\/10.3390\/pharmaceutics16091197","DOI":"10.3390\/pharmaceutics16091197"},{"issue":"1","key":"11188_CR205","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11033-025-10709-7","volume":"52","author":"MA Butt","year":"2025","unstructured":"Butt, M. A., Tabassum, S., Hardy, R. S., & Kiyani, M. M. (2025). Mechanistic insight into nanomedicine for polycystic ovary syndrome. Molecular biology reports, 52(1), 618. https:\/\/doi.org\/10.1007\/s11033-025-10709-7","journal-title":"Molecular biology reports"},{"key":"11188_CR206","doi-asserted-by":"publisher","unstructured":"Liu, X., Gao, M., & Bao, J. (2025). Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications. Nanomaterials (Basel, Switzerland), 15(7). https:\/\/doi.org\/10.3390\/nano15070540","DOI":"10.3390\/nano15070540"},{"key":"11188_CR207","doi-asserted-by":"publisher","DOI":"10.1039\/d2tb02610d","author":"MW Ghani","year":"2023","unstructured":"Ghani, M. W., Iqbal, A., Ghani, H., Bibi, S., Wang, Z., & Pei, R. (2023). Recent advances in nanocomposite-based delivery systems for targeted CRISPR\/Cas delivery and therapeutic genetic manipulation. Journal of Materials Chemistry B. https:\/\/doi.org\/10.1039\/d2tb02610d","journal-title":"Journal of Materials Chemistry B"},{"key":"11188_CR208","doi-asserted-by":"publisher","unstructured":"Liu, G., Dai, L., Zhang, R., Jia, M., Lan, S., Sun, X., \u2026 Yang, S. (2025). Selenium nanoparticles mitigate Cyclophosphamide-Induced premature ovarian failures in mice by activating PI3K\/AKT signaling pathway and inhibiting ferroptosis. Journal of Ovarian Research, 18(1), 257. https:\/\/doi.org\/10.1186\/s13048-025-01825-w","DOI":"10.1186\/s13048-025-01825-w"},{"key":"11188_CR209","doi-asserted-by":"publisher","unstructured":"Cho, E. Y., Ryu, J. Y., Lee, H. A. R., Hong, S. H., Park, H. S., Hong, K. S., \u2026 Yoon, T. J. (2019). Lecithin nano-liposomal particle as a CRISPR\/Cas9 complex delivery system for treating type 2 diabetes. Journal of Nanobiotechnology, 17(1). https:\/\/doi.org\/10.1186\/s12951-019-0452-8","DOI":"10.1186\/s12951-019-0452-8"},{"key":"11188_CR210","doi-asserted-by":"publisher","unstructured":"Kurata, M., Wolf, N. K., Lahr, W. S., Weg, M. T., Kluesner, M. G., Lee, S., \u2026 Moriarity, B. S. (2018). Highly multiplexed genome engineering using CRISPR\/Cas9 gRNA arrays. PLoS ONE, 13(9). https:\/\/doi.org\/10.1371\/journal.pone.0198714","DOI":"10.1371\/journal.pone.0198714"},{"key":"11188_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01500-6","author":"H Cheng","year":"2025","unstructured":"Cheng, H., Jeong, E., & Cho, S. W. (2025). Applications of multiplexed CRISPR\u2013Cas for genome engineering. Experimental and Molecular Medicine. https:\/\/doi.org\/10.1038\/s12276-025-01500-6","journal-title":"Experimental and Molecular Medicine"},{"key":"11188_CR212","doi-asserted-by":"publisher","unstructured":"Doman, J. L., Sousa, A. A., Randolph, P. B., Chen, P. J., & Liu, D. R. (2022). Designing and executing prime editing experiments in mammalian cells. Nature Protocols, 17(11). https:\/\/doi.org\/10.1038\/s41596-022-00724-4","DOI":"10.1038\/s41596-022-00724-4"},{"key":"11188_CR213","doi-asserted-by":"publisher","unstructured":"Findlay, G. M., Boyle, E. A., Hause, R. J., Klein, J. C., & Shendure, J. (2014). Saturation editing of genomic regions by multiplex homology-directed repair. Nature, 513(7516). https:\/\/doi.org\/10.1038\/nature13695","DOI":"10.1038\/nature13695"},{"key":"11188_CR214","doi-asserted-by":"publisher","unstructured":"Sahu, S., Sullivan, T., Southon, E., Caylor, D., Geh, J., & Sharan, S. K. (2023). Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9. STAR Protocols, 4(4). https:\/\/doi.org\/10.1016\/j.xpro.2023.102702","DOI":"10.1016\/j.xpro.2023.102702"},{"key":"11188_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02439-1","author":"O Belli","year":"2025","unstructured":"Belli, O., Karava, K., Farouni, R., & Platt, R. J. (2025). Multimodal scanning of genetic variants with base and prime editing. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-024-02439-1","journal-title":"Nature Biotechnology"},{"key":"11188_CR216","doi-asserted-by":"publisher","unstructured":"Wu, Y., Zhong, A., Sidharta, M., Kim, T. W., Ramirez, B., Persily, B., \u2026 Zhou, T. (2024). Robust and inducible genome editing via an all-in-one prime editor in human pluripotent stem cells. Nature Communications , 15(1). https:\/\/doi.org\/10.1038\/s41467-024-55104-1","DOI":"10.1038\/s41467-024-55104-1"},{"key":"11188_CR217","doi-asserted-by":"publisher","unstructured":"Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., \u2026 Kazmi, I. (2022). Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10030540","DOI":"10.3390\/biomedicines10030540"},{"issue":"1","key":"11188_CR218","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40364-024-00618-5","volume":"12","author":"T Wu","year":"2024","unstructured":"Wu, T., Hu, Y., & Tang, L. V. (2024). Gene therapy for polygenic or complex diseases. Biomarker Research, 12(1), 99. https:\/\/doi.org\/10.1186\/s40364-024-00618-5","journal-title":"Biomarker Research"},{"issue":"2","key":"11188_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2025.101017","volume":"25","author":"V Dharani","year":"2025","unstructured":"Dharani, V., Nishu, S., & Hariprasath, L. (2025). PCOS and genetics: Exploring the heterogeneous role of potential genes in ovarian dysfunction, a hallmark of PCOS \u2013 A review. Reproductive Biology, 25(2), Article 101017. https:\/\/doi.org\/10.1016\/j.repbio.2025.101017","journal-title":"Reproductive Biology"},{"key":"11188_CR220","doi-asserted-by":"publisher","unstructured":"Gao, X., Zhao, S., Du, Y., Yang, Z., Tian, Y., Zhao, J., \u2026 Network, C. W. R. M. (2025). Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes. Nature Medicine. https:\/\/doi.org\/10.1038\/s41591-025-03984-1","DOI":"10.1038\/s41591-025-03984-1"},{"key":"11188_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1143157","author":"C Guo","year":"2023","unstructured":"Guo, C., Ma, X., Gao, F., & Guo, Y. (2023). Off-target effects in CRISPR\/Cas9 gene editing. Frontiers in Bioengineering and Biotechnology. https:\/\/doi.org\/10.3389\/fbioe.2023.1143157","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"11188_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.02.027","author":"M Khoshandam","year":"2024","unstructured":"Khoshandam, M., Soltaninejad, H., Mousazadeh, M., Hamidieh, A. A., & Hosseinkhani, S. (2024). Clinical applications of the CRISPR\/Cas9 genome-editing system: Delivery options and challenges in precision medicine. Genes and Diseases. https:\/\/doi.org\/10.1016\/j.gendis.2023.02.027","journal-title":"Genes and Diseases"},{"issue":"21","key":"11188_CR223","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2217\/epi-2023-0281","volume":"15","author":"SM Fadul","year":"2023","unstructured":"Fadul, S. M., Arshad, A., & Mehmood, R. (2023). CRISPR-based epigenome editing: Mechanisms and applications. Epigenomics, 15(21), 1137\u20131155. https:\/\/doi.org\/10.2217\/epi-2023-0281","journal-title":"Epigenomics"},{"key":"11188_CR224","doi-asserted-by":"publisher","unstructured":"Ito, Y., Inoue, S., Nakashima, T., Zhang, H., Li, Y., Kasuya, H., \u2026 Kagoya, Y. (2024). Epigenetic profiles guide improved CRISPR\/Cas9-mediated gene knockout in human T cells. Nucleic acids research, 52(1), 141\u2013153. https:\/\/doi.org\/10.1093\/nar\/gkad1076","DOI":"10.1093\/nar\/gkad1076"},{"issue":"6","key":"11188_CR225","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-024-01706-w","volume":"56","author":"C Policarpi","year":"2024","unstructured":"Policarpi, C., Munaf\u00f2, M., Tsagkris, S., Carlini, V., & Hackett, J. A. (2024). Systematic epigenome editing captures the context-dependent instructive function of chromatin modifications. Nature Genetics, 56(6), 1168\u20131180. https:\/\/doi.org\/10.1038\/s41588-024-01706-w","journal-title":"Nature Genetics"},{"key":"11188_CR226","doi-asserted-by":"publisher","DOI":"10.1007\/s41649-018-0056-x","author":"G Rubeis","year":"2018","unstructured":"Rubeis, G., & Steger, F. (2018). Risks and benefits of human germline genome editing: An ethical analysis. Asian Bioethics Review. https:\/\/doi.org\/10.1007\/s41649-018-0056-x","journal-title":"Asian Bioethics Review"},{"key":"11188_CR227","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-112717-094629","author":"BS Coller","year":"2019","unstructured":"Coller, B. S. (2019). Ethics of human genome editing. Annual Review of Medicine. https:\/\/doi.org\/10.1146\/annurev-med-112717-094629","journal-title":"Annual Review of Medicine"},{"issue":"2","key":"11188_CR228","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10730-024-09538-1","volume":"37","author":"L Wiley","year":"2025","unstructured":"Wiley, L., Cheek, M., LaFar, E., Ma, X., Sekowski, J., Tanguturi, N., & Iltis, A. (2025). The ethics of human embryo editing via CRISPR-Cas9 technology: A systematic review of ethical arguments, reasons, and concerns. HEC Forum, 37(2), 267\u2013303. https:\/\/doi.org\/10.1007\/s10730-024-09538-1","journal-title":"HEC Forum"},{"key":"11188_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.09.009","author":"T Ishii","year":"2017","unstructured":"Ishii, T. (2017). Reproductive medicine involving genome editing: Clinical uncertainties and embryological needs. Reproductive BioMedicine Online. https:\/\/doi.org\/10.1016\/j.rbmo.2016.09.009","journal-title":"Reproductive BioMedicine Online"},{"key":"11188_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2025.1553590","volume":"7","author":"J-J Cabr\u00e9-Romans","year":"2025","unstructured":"Cabr\u00e9-Romans, J.-J., & Cuella-Martin, R. (2025). CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders. Frontiers in Genome Editing, 7, Article 1553590. https:\/\/doi.org\/10.3389\/fgeed.2025.1553590","journal-title":"Frontiers in Genome Editing"},{"key":"11188_CR231","doi-asserted-by":"publisher","unstructured":"Abbasi, F., Kodani, M., Emori, C., Kiyozumi, D., Mori, M., Fujihara, Y., & Ikawa, M. (2020). CRISPR\/Cas9-Mediated Genome Editing Reveals Oosp Family Genes are Dispensable for Female Fertility in Mice. Cells, 9(4). https:\/\/doi.org\/10.3390\/cells9040821","DOI":"10.3390\/cells9040821"},{"key":"11188_CR232","doi-asserted-by":"publisher","unstructured":"Kosta, S., & Singh, M. (2025). AI-Driven Polygenic Risk Scores and Genetic Insights for Polycystic Ovary Syndrome (PCOS) Susceptibility and Diagnosis. In Z. Wang (Ed.), Understanding Polycystic Ovary Syndrome - Symptoms, Diagnosis, and Treatment Options. London: IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.1012249","DOI":"10.5772\/intechopen.1012249"},{"key":"11188_CR233","doi-asserted-by":"publisher","unstructured":"Zhang, R., Yang, Y., Li, R., Ma, Y., Ma, S., Chen, X., \u2026 Ha, C. (2025). Construction organoid model of ovarian endometriosis and the function of estrogen and progesterone in the model. Scientific Reports, 15(1), 6636. https:\/\/doi.org\/10.1038\/s41598-025-90329-0","DOI":"10.1038\/s41598-025-90329-0"},{"key":"11188_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-025-00907-1","author":"T Thomson","year":"2025","unstructured":"Thomson, T., Li, G., Strilchuk, A., Cui, H., Wang, B., & Li, B. (2025). Harnessing artificial intelligence to advance CRISPR-based genome editing technologies. Nature Reviews Genetics. https:\/\/doi.org\/10.1038\/s41576-025-00907-1","journal-title":"Nature Reviews Genetics"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11188-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:58:52Z","timestamp":1788764332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11188-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":234,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11188"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11188-4","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The review was written after a thorough search of the literature using the terms \u201cpolycystic ovarian syndrome\/polyendocrine metabolic ovarian syndrome\u201d, \u201cgenome-wide association study\u201d, \u201cCRISPR\/Cas9\u201d, \u201chuman embryonic stem cells\u201d, \u201chuman induced pluripotent stem cells\u201d, \u201cmesenchymal stem cells\u201d in the PubMed database. Only articles written in English were included.","order":1,"name":"Ethics","label":"Search Methods","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Registration Date in the manuscript for the Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}